Original source text
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Mattel, Inc. (NASDAQ: MAT) announced today that Barbie is introducing a doll in the likeness of professional basketball superstar, entrepreneur, and philanthropist Angel Reese, celebrating her influence on sport, business, fashion, and culture while empowering the next generation of girls to dream without limits. Dressed in signature Barbie style, the doll debuts in Reebok Angel Reese 1 Basketball Shoes in Barbie pink, with a matching pair available for fans. Live financial news intelligence
Track market-moving stories before they get noisy
Real-time pulse of financial headlines curated from 5 premium feeds.
Latest market signal
English
Commodities
GOLD
159
SILVER
94
OIL
52
PLATINUM
5
PALLADIUM
2
COPPER
1
- FMP Stock News 17s ago
- FMP Forex News 1m ago
- CoinGecko News 1m ago
- FIO Stock News 5m ago
- Patria Stock News 5m ago
- Editorial rewrite 17s ago
- Asset sync 15m ago
Latest coverage
Market News Feed
Scan headlines quickly, then expand any story for source context.
| Details | Date | Content | Source |
|---|---|---|---|
|
Saved
2026-07-24 15:20
2d ago
Published
2026-07-24 09:00
2d ago
|
Barbie® Celebrates Basketball Superstar Angel Reese with a Barbie Signature Doll and Matching Reebok Angel Reese 1 Basketball Shoes | FMP Stock News | |
|
|
|||
|
Saved
2026-07-24 15:17
2d ago
Published
2026-07-24 09:59
2d ago
|
Why Tenet Healthcare Stock Is Surging 23% Today While This Rival Lags Behind | FMP Stock News | |
|
Original source text
In this articleTHC HCA SPX Tenet Healthcare and HCA Healthcare oversee U.S.-based networks of hospitals, clinics, and outpatient surgery centers. (Dreamstime) Shares of Tenet Healthcare outpaced hospital operator peer HCA Healthcare as the companies presented two very different pictures to Wall Street on Friday, sending Tenet stock sharply higher while HCA posted a more modest gain. |
|||
|
Saved
2026-07-24 15:17
2d ago
Published
2026-07-24 11:01
2d ago
|
Eaton (ETN) Reports Next Week: Wall Street Expects Earnings Growth | FMP Stock News | |
|
Original source text
Eaton (ETN - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on July 31, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise. Zacks Consensus EstimateThis power management company is expected to post quarterly earnings of $3.08 per share in its upcoming report, which represents a year-over-year change of +4.4%. Revenues are expected to be $8 billion, up 13.9% from the year-ago quarter. Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.25% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS Surprise Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). How Have the Numbers Shaped Up for Eaton?For Eaton, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.32%. On the other hand, the stock currently carries a Zacks Rank of #2. So, this combination indicates that Eaton will most likely beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Eaton would post earnings of $2.74 per share when it actually produced earnings of $2.81, delivering a surprise of +2.55%. Over the last four quarters, the company has beaten consensus EPS estimates three times. Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Eaton appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. An Industry Player's Expected ResultsAmong the stocks in the Zacks Manufacturing - Electronics industry, A.O. Smith (AOS - Free Report) , is soon expected to post earnings of $0.96 per share for the quarter ended June 2026. This estimate indicates a year-over-year change of -10.3%. This quarter's revenue is expected to be $986.45 million, down 2.5% from the year-ago quarter. The consensus EPS estimate for A.O. Smith has been revised 0.2% lower over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -2.08%. When combined with a Zacks Rank of #4 (Sell), this Earnings ESP makes it difficult to conclusively predict that A.O. Smith will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. |
|||
|
Saved
2026-07-24 15:17
2d ago
Published
2026-07-24 10:16
2d ago
|
Gear Up for Equinix (EQIX) Q2 Earnings: Wall Street Estimates for Key Metrics | FMP Stock News | |
|
Original source text
Wall Street analysts expect Equinix (EQIX - Free Report) to post quarterly earnings of $11.25 per share in its upcoming report, which indicates a year-over-year increase of 13.5%. Revenues are expected to be $2.59 billion, up 14.8% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights. Bearing this in mind, let's now explore the average estimates of specific Equinix metrics that are commonly monitored and projected by Wall Street analysts. The consensus estimate for 'Revenues- Non-recurring revenues' stands at $180.54 million. The estimate indicates a year-over-year change of +59.8%. The average prediction of analysts places 'Revenues- Recurring revenues' at $2.41 billion. The estimate indicates a year-over-year change of +12.4%. Analysts expect 'Revenues- Recurring revenues- Managed infrastructure' to come in at $121.73 million. The estimate indicates a change of +4% from the prior-year quarter. Analysts' assessment points toward 'Revenues- Recurring revenues- Colocation' reaching $1.78 billion. The estimate points to a change of +12.3% from the year-ago quarter. The combined assessment of analysts suggests that 'Geographic Revenues- Asia-Pacific' will likely reach $552.39 million. The estimate suggests a change of +13.9% year over year. Based on the collective assessment of analysts, 'Geographic Revenues- EMEA' should arrive at $860.34 million. The estimate suggests a change of +12.2% year over year. It is projected by analysts that the 'Geographic Revenues- Americas' will reach $1.18 billion. The estimate points to a change of +17.3% from the year-ago quarter. The collective assessment of analysts points to an estimated 'Geographic Revenues- EMEA- Non-recurring' of $39.42 million. The estimate indicates a change of +12.6% from the prior-year quarter. Analysts forecast 'Quarter End Utilization - Worldwide' to reach 77.7%. Compared to the current estimate, the company reported 78.0% in the same quarter of the previous year. Analysts predict that the 'Cabinet Equivalent Capacity - EMEA' will reach 142,763 . Compared to the present estimate, the company reported 137,800 in the same quarter last year. The consensus among analysts is that 'Cabinet Equivalent Capacity - APAC' will reach 96,000 . Compared to the present estimate, the company reported 89,900 in the same quarter last year. According to the collective judgment of analysts, 'Quarter End Utilization - EMEA' should come in at 77.2%. Compared to the current estimate, the company reported 77.0% in the same quarter of the previous year. View all Key Company Metrics for Equinix here>>> Over the past month, Equinix shares have recorded returns of -5% versus the Zacks S&P 500 composite's +0.6% change. Based on its Zacks Rank #3 (Hold), EQIX will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> . |
|||
|
Saved
2026-07-24 15:17
2d ago
Published
2026-07-24 10:37
2d ago
|
PRIM Investors Have Opportunity to Lead Primoris Services Corporation Securities Fraud Lawsuit with the Schall Law Firm | FMP Stock News | |
|
Original source text
LOS ANGELES, July 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Primoris Services Corporation (“Primoris” or “the Company”) (NYSE: PRIM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 5, 2025 and June 22, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before September 21, 2026. |
|||
|
Saved
2026-07-24 15:16
2d ago
Published
2026-07-24 11:11
2d ago
|
Service Corporation Q2 Earnings on Deck: Factors to Watch for SCI | FMP Stock News | |
|
Original source text
Key Takeaways SCI's second-quarter revenues are expected to increase about 1% to $1.1 billion. Preneed cemetery sales, better leads and community outreach likely supported contract growth. Pricing may lift funeral revenues, but soft volumes and higher costs could pressure margins. Service Corporation International (SCI - Free Report) is likely to witness top-line growth when it reports second-quarter 2026 earnings on July 29. The Zacks Consensus Estimate for revenues is pegged at $1.1 billion, indicating an increase of about 1% from the prior-year quarter’s reported figure.The consensus mark for earnings has remained unchanged over the past 30 days at 87 cents a share, which suggests a decline of 1.1% from the figure reported in the year-ago period. SCI has a trailing four-quarter surprise of 1.7%, on average. Factors Likely to Influence SCI’s Upcoming ResultsSCI’s cemetery performance is likely to have benefited from sustained preneed sales momentum. Investments in salesforce retention and hiring, improved lead quality, expanded seminars and community-based outreach are likely to have continued to support contract velocity and customer reach beyond funeral-home-generated leads. Funeral revenues are anticipated to have benefited from disciplined pricing and favorable average revenue per service. Management previously stated that average revenue per service was expected to continue benefiting from older preneed contracts maturing, with accumulated trust earnings and newer, higher-value contracts entering the backlog. However, funeral service volumes are likely to have remained a key headwind. Management indicated that April volumes were still down, though the decline was less severe than in the first quarter, and expected improvement only gradually through the quarter. The company’s high fixed-cost structure may also have limited margin expansion if funeral volumes remained soft. Higher selling compensation tied to preneed production and elevated cemetery maintenance costs could have added to margin pressure. Earnings Whispers for SCIOur proven model doesn’t conclusively predict an earnings beat for SCI this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here. SCI currently carries a Zacks Rank #3 and has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. Stocks With the Favorable CombinationHere are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings this reporting cycle. Archer-Daniels-Midland Company (ADM - Free Report) currently has an Earnings ESP of +11.52% and a Zacks Rank of 2. The consensus estimate for ADM’s quarterly revenues is pinned at $22.4 billion, which calls for 5.7% growth from the figure reported in the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for Archer-Daniels’ upcoming quarter’s EPS is pegged at $1.27, which implies a 36.6% rise year over year. ADM delivered a trailing four-quarter earnings surprise of 5.4%, on average. Kimberly-Clark Corporation (KMB - Free Report) currently has an Earnings ESP of +1.43% and a Zacks Rank of 3. The Zacks Consensus Estimate for Kimberly-Clark’s upcoming quarterly revenues is pegged at $4.2 billion. The figure indicates a 1.7% increase from the prior-year quarter. The Zacks Consensus Estimate for Kimberly-Clark’s quarterly earnings per share is pegged at $2.00, calling for a 4.2% gain from the year-ago period figure. KMB delivered a trailing four-quarter earnings surprise of 19.1%, on average. Monster Beverage Corporation (MNST - Free Report) currently has an Earnings ESP of +2.61% and a Zacks Rank of 3. The consensus estimate for Monster Beverage’s quarterly revenues is pinned at $2.4 billion, which suggests 14.5% growth from the figure reported in the prior-year quarter. The Zacks Consensus Estimate for the upcoming quarter’s EPS is pegged at 59 cents, which calls for a 13.5% jump year over year. MNST delivered a trailing four-quarter earnings surprise of 9.6%, on average. |
|||
|
Saved
2026-07-24 15:16
2d ago
Published
2026-07-24 10:41
2d ago
|
AMN Healthcare Services (AMN) is a Top-Ranked Value Stock: Should You Buy? | FMP Stock News | |
|
Original source text
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days. Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform. The Style Scores are broken down into four categories: Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks. Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth. Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks. VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum. How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio. Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day. With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey. That's where the Style Scores come in. You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible. The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank. Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too. Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement. AMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 12.25; value investors should take notice. For fiscal 2026, one analyst revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.17 to $2.70 per share. AMN boasts an average earnings surprise of +53.3%. With a solid Zacks Rank and top-tier Value and VGM Style Scores, AMN should be on investors' short list. |
|||
|
Saved
2026-07-24 15:16
2d ago
Published
2026-07-24 11:01
2d ago
|
RBC Bearings (RBC) Earnings Expected to Grow: Should You Buy? | FMP Stock News | |
|
Original source text
RBC Bearings (RBC - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. Zacks Consensus EstimateThis maker of bearings and components is expected to post quarterly earnings of $3.42 per share in its upcoming report, which represents a year-over-year change of +20.4%. Revenues are expected to be $508.64 million, up 16.7% from the year-ago quarter. Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.57% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS Surprise Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction). The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). How Have the Numbers Shaped Up for RBC Bearings?For RBC Bearings, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.66%. On the other hand, the stock currently carries a Zacks Rank of #2. So, this combination indicates that RBC Bearings will most likely beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that RBC Bearings would post earnings of $3.31 per share when it actually produced earnings of $3.62, delivering a surprise of +9.37%. Over the last four quarters, the company has beaten consensus EPS estimates four times. Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. RBC Bearings appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. An Industry Player's Expected ResultsAnother stock from the Zacks Manufacturing - General Industrial industry, Idex (IEX - Free Report) , is soon expected to post earnings of $2.1 per share for the quarter ended June 2026. This estimate indicates a year-over-year change of +1.5%. Revenues for the quarter are expected to be $902.43 million, up 4.3% from the year-ago quarter. Over the last 30 days, the consensus EPS estimate for Idex has been revised 0.1% down to the current level. Nevertheless, the company now has an Earnings ESP of -0.67%, reflecting a lower Most Accurate Estimate. When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that Idex will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. |
|||
|
Saved
2026-07-24 15:15
2d ago
Published
2026-07-24 09:00
2d ago
|
Simpson Manufacturing Co., Inc. Declares Quarterly Dividend | FMP Stock News | |
|
Original source text
, /PRNewswire/ -- Simpson Manufacturing Co., Inc. (the "Company") (NYSE: SSD), an industry leader in engineered structural connectors and building solutions, today announced that on July 23, 2026, the Company's Board of Directors (the "Board") declared a regular quarterly dividend of 30 cents per share on the Company's common stock. The dividend is payable on October 22, 2026, to stockholders of record on October 1, 2026.About Simpson Manufacturing Co., Inc. Simpson Manufacturing Co., Inc., headquartered in Pleasanton, California, through its subsidiaries, including Simpson Strong-Tie Company Inc., designs, engineers and is a leading manufacturer of wood construction products, including connectors, truss plates, fastening systems, fasteners and shear walls, and concrete construction products, including adhesives, specialty chemicals, mechanical anchors, powder actuated tools and reinforcing fiber materials. The Company primarily supplies its building product solutions to both the residential and commercial markets in North America and Europe. The Company's common stock trades on the New York Stock Exchange under the symbol "SSD." CONTACT: Addo Investor Relations [email protected] (310) 829-5400 SOURCE Simpson Manufacturing Co., Inc. |
|||
|
Saved
2026-07-24 15:15
2d ago
Published
2026-07-24 09:56
2d ago
|
Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises | FMP Stock News | |
|
Original source text
Key Takeaways Edwards Lifesciences topped Q2 earnings and revenue estimates, with shares rising nearly 3% after hours.EW raised 2026 sales growth guidance as TAVR demand and TMTT adoption remained strong.Edwards Lifesciences reaffirmed 2026 earnings guidance and expects Q3 revenues of $1.63B-$1.71B. Edwards Lifesciences Corporation (EW - Free Report) reported second-quarter 2026 adjusted earnings of 78 cents per share, up 16.4% year over year. The figure surpassed the Zacks Consensus Estimate by 6.8%.Revenues rose 13.6% to $1.74 billion and topped the consensus mark by 2.4%. Growth was driven by strong Transcatheter Aortic Valve Replacement (“TAVR”) demand and rapid adoption of the company’s mitral and tricuspid therapies. Following the announcement yesterday, EW shares jumped nearly 3% in after-hours trading. EW’s Segment Sales Reflect Broad-Based GrowthTAVR sales totaled $1.26 billion, up 11.3% year over year on a reported basis and 10.5% at constant currency. Growth was similar in the United States and international markets, supported by procedural momentum, clinical evidence favoring proactive treatment of severe aortic stenosis and continued adoption of the SAPIEN 3 Ultra RESILIA platform. Transcatheter Mitral and Tricuspid Therapies (“TMTT”) sales reached $195.9 million, rising 47.3% year over year and 44.8% at constant currency. Double-digit growth in mitral and tricuspid procedures, increased adoption of PASCAL, the continued scaling of EVOQUE and the measured rollout of SAPIEN M3 drove the segment’s performance. Surgical sales were $284 million, increasing 6.5% year over year and 5% at constant currency. Growth reflected continued adoption of RESILIA-based therapies, including INSPIRIS, MITRIS and KONECT. Edwards also received U.S. approval for ECLIPTIS and plans a measured rollout later in 2026. Edwards’ Margins Reflect Earnings LeverageAdjusted gross margin was 77.6%, unchanged from the year-ago quarter. Foreign exchange created a 70 basis points (bps) headwind, which was offset by lower manufacturing expenses. Selling, general and administrative (SG&A) expenses increased to $561 million from $502 million, while research and development (R&D) expenses rose to $279 million from $276 million. Adjusted operating income jumped 20.8% year over year to $522.7 million. The adjusted operating margin expanded 180 bps to 30%, supported by strong revenue growth and the planned timing of strategic investments in R&D and SG&A. Edwards Maintains Financial FlexibilityAs of June 30, 2026, the company had approximately $2.90 billion in cash and cash equivalents. Total debt was about $600 million, leaving Edwards with substantial liquidity to support organic investment, manufacturing expansion and external opportunities in structural heart therapies. The company also had roughly $1.50 billion remaining under its share-repurchase authorization. Management continues to prioritize growth investments before opportunistic capital returns. EW Raises Sales Outlook and Reaffirms Earnings ViewEdwards increased its 2026 constant-currency sales growth guidance to 10-11% from the earlier 9-11%. Breaking it down, TAVR growth guidance was raised to 8-9% from 7-9%, while the TMTT sales outlook increased to $760-$780 million from $740-$780 million. Surgical sales are still expected to grow at a mid-single-digit rate. Overall, EW now expects total sales of $6.60-$6.90 billion at current exchange rates. The Zacks Consensus Estimate for the same currently stands at $6.74 billion. The company reaffirmed adjusted earnings guidance of $2.95-$3.05 per share despite expecting its tax rate to be at the high end of the prior 16-19% range. The Zacks Consensus Estimate for the metric is pegged at $3.00 at present. For the third quarter of 2026, Edwards expects revenues of $1.63-$1.71 billion and adjusted earnings of 71-77 cents per share. The consensus mark for third-quarter revenues and earnings per share (EPS) is projected at $1.69 billion and 74 cents, respectively. Our TakeEdwards exited the second quarter of 2026 with both earnings and revenues beating estimates. Performance reflected the strength of its comprehensive portfolio and agile execution, with growth supported by therapies across TAVR, mitral, tricuspid and surgical, as well as favorable contributions from each of the regions. Within TAVR, Edwards’ competitive position in the United States is supported by continued adoption of its SAPIEN 3 Ultra RESILIA platform. TMTT benefited from the ongoing strong uptake of the PASCAL system. The expansion of adjusted operating margin in the quarter is also encouraging. EW’s Zacks Rank and Key PicksEdwards currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the broader medical space are Intuitive Surgical (ISRG - Free Report) , Danaher (DHR - Free Report) and Elevance Health (ELV - Free Report) . Intuitive Surgical, carrying a Zacks Rank #2 (Buy), reported second-quarter 2026 adjusted EPS of $2.80, which surpassed the Zacks Consensus Estimate by 12.9%. Revenues of $2.89 billion beat the Zacks Consensus Estimate by 3.1%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. ISRG has an earnings yield of 3.1% compared to the industry’s negative 3% yield. The company beat earnings estimates in each of the trailing four quarters, the average surprise being 16.53%. Danaher, carrying a Zacks Rank #2 at present, posted second-quarter 2026 adjusted EPS of $1.94, exceeding the Zacks Consensus Estimate by 5.44%. Revenues of $6.27 billion topped the Zacks Consensus Estimate by 2.88%. DHR has an earnings yield of 4.7% compared with the industry’s 4.1% yield. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 5.65%. Elevance Health, carrying a Zacks Rank #2 at present, posted second-quarter 2026 adjusted EPS of $7.45, exceeding the Zacks Consensus Estimate by 20.6%. Revenues of $49.8 billion outperformed the consensus mark by 0.8%. ELV has an earnings yield of 6.9% compared to the industry’s 4.1% yield. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 5.65%. |
|||
|
Saved
2026-07-24 15:15
2d ago
Published
2026-07-24 11:06
2d ago
|
Oceaneering Q2 Earnings & Revenues Rise Y/Y, Adjusted EBITDA Up | FMP Stock News | |
|
Original source text
Key Takeaways OII posted higher Q2 profit and revenues, led by gains across four business segments.Oceaneering expects Q3 revenue growth with EBITDA of $115M-$125M and strength in SSR, OPG and ADTech.OII raised 2026 adjusted EBITDA guidance to $400M-$440M while lowering the IMDS profit outlook. Oceaneering International, Inc. (OII - Free Report) reported second-quarter 2026 earnings of 65 cents per share, up from 54 cents in the year-ago quarter. Higher year-over-year operating income from the company's Subsea Robotics, Manufactured Products, Offshore Projects Group and Aerospace and Defense Technologies segments contributed to this improvement.Total revenues were $768.2 million, increased approximately 10% from the year-ago quarter’s $698.2 million. This increase reflected revenue growth across all segments except Integrity Management & Digital Solutions. In the second quarter of 2026, the Houston, TX-based oil and gas equipment and services company reported adjusted EBITDA of $114.5 million, up 10.9% year over year. Operating income increased 11% year over year to $88.2 million. Gross margin expanded to $157 million from $148.4 million, reflecting revenue growth and improved performance across most operating segments. Q2 Segmental Information of OceaneeringSubsea Robotics (SSR): The unit provides remotely operated submersible vehicles for drill support, vessel-based inspection, subsea hardware installation, pipeline surveys and maintenance services. Revenues totaled $232 million compared with the year-ago quarter’s $218.8 million. The segment also reported an operating income of $66.3 million compared with $64.5 million a year ago. The company's segment delivered an EBITDA margin of 35% in the second quarter of 2026, flat compared with the year-ago quarter. Revenue per day for remotely operated vehicles (“ROV”) rose to $11,894, while ROV fleet utilization slightly decreased to 66%. Manufactured Products: The segment focuses on the manufactured products business, theme park entertainment systems and automated guided vehicles. Revenues totaled $149 million compared with the year-ago quarter’s $145.1 million. The segment posted an operating profit of $21.9 million in the second quarter, up from the year-ago quarter’s $18.8 million. The backlog totaled $445 million as of June 30, 2026, down 13.8% from the same time in 2025. For the 12 months ending June 30, 2026, the book-to-bill ratio was 0.88. Offshore Projects Group (OPG): This segment involves Oceaneering’s former Subsea Projects unit, excluding survey services and global data solutions, the service and rental business and ROV tooling. Revenues increased about 22.5% to $182.8 million from $149.3 million in the year-ago quarter. The unit’s operating income totaled $30 million compared with the prior-year quarter’s $21.7 million. The company’s operating income margin slightly increased to 16% from the prior-year quarter’s 15%, reflecting favorable project mix and disciplined execution. Integrity Management & Digital Solutions (IMDS): This segment covers Oceaneering’s Asset Integrity unit, along with its global data solutions business. Revenues of $70.8 million decreased from the year-ago quarter’s $75.4 million. Operating income decreased to $0.1 million from $4.6 million due to lower activity, weaker cost absorption and higher personnel-related costs in West Africa and the Middle East. Aerospace and Defense Technologies (ADTech): The segment is engaged in Oceaneering’s government business, which focuses on defense subsea technologies, marine services and space systems. Revenues totaled $133.5 million, up from $109.6 million recorded in the second quarter of 2025. The operating income increased to $16.4 million from $16.3 million in the year-ago quarter. Operating income margin decreased to 12% from 15% in the year-ago quarter due to program mix and timing. OII’s Capital Expenditure & Balance SheetThe capital expenditure in the second quarter, including acquisitions, totaled $30.8 million. As of June 30, 2026, OII had cash and cash equivalents worth $629.5 million and $688.9 million, respectively, along with a long-term debt of about $490.2 million. The debt-to-capitalization was 29.6%. The company repurchased 263,335 shares for approximately $10 million. OII also issued $500 million of senior notes due 2034 and increased its revolving credit commitments to $345 million from $215 million. Q3 and 2026 Outlook by OceaneeringThis Zacks Rank #3 (Hold) company expects consolidated revenues to increase in the third quarter of 2026, with EBITDA projected in the range of $115 million to $125 million. At the segment level, SSR is expected to post growth in both revenues and operating income. Manufactured Products is projected to witness slight declines in revenues and operating income. OPG is anticipated to deliver increases in both revenues and operating income. IMDS revenues are expected to increase, while operating income is likely to remain relatively flat. Meanwhile, ADTech is forecasted to report higher revenues and operating income. Unallocated expenses are expected to be in the $50 million range. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here Management expressed confidence in the company's outlook for the remainder of 2026, supported by strong first-half execution, healthy demand across most of its businesses and an improved financial position. The company expects offshore activity to continue strengthening, driven by higher rig utilization, longer-duration contracts and sustained demand for subsea services. Management also expects Subsea Robotics to benefit from higher ROV utilization and continued survey vessel activity, while the Manufactured Products backlog is anticipated to improve in the second half of 2026, supported by recent contract awards and additional opportunities in the sales pipeline. Despite ongoing uncertainty in the Middle East and lower activity in West Africa affecting the IMDS business, management believes the performance of its other operating segments remains in line with or ahead of prior expectations. The company updated its full-year 2026 consolidated adjusted EBITDA outlook to a range of $400 million to $440 million. OII retained its previously issued consolidated and segment guidance, except that IMDS operating income is now expected to decline significantly, with the operating income margin projected to be in the low-single-digit percentage range. Important Energy Earnings at a GlanceWhile we have discussed OII’s second-quarter results in detail, let us take a look at three other key reports in the energy space. Houston, TX-based oil and gas equipment and services provider Halliburton (HAL - Free Report) posted second-quarter 2026 adjusted net income per share of 55 cents, marginally beating the Zacks Consensus Estimate of 54 cents. The outperformance was backed by year-over-year revenue growth. However, the bottom line was flat compared with the prior-year level. As of June 30, 2026, Halliburton had approximately $2 billion in cash and cash equivalents and $7.1 billion in long-term debt, representing a debt-to-capitalization of 39%. Fort Worth, TX-based oil and gas exploration and production company Range Resources Corporation (RRC - Free Report) reported second-quarter 2026 adjusted earnings of 79 cents per share, up 19.7% from 66 cents a year ago. Range Resources’ bottom line topped the Zacks Consensus Estimate of 56 cents by 41.1%. Strong quarterly results are driven by higher production and improved price realization. Range Resources’ net debt was $880.8 million at June 30, 2026, down 28% from $1.22 billion at year-end 2025. It repurchased $78 million of shares and paid $24 million in dividends during the quarter. Houston, TX-based oil and gas storage and transportation company Kinder Morgan, Inc. (KMI - Free Report) reported second-quarter 2026 adjusted earnings of 37 cents per share, beating the Zacks Consensus Estimate of 31 cents by 19.35%. Earnings increased 32.1% from 28 cents per share in the year-ago quarter. Strong quarterly results benefited from broad-based segment growth, led by higher natural gas transportation and gathering volumes. Natural gas transport volumes rose 7%, while gathering volumes increased 26%. As of June 30, 2026, Kinder Morgan reported $89 million in cash and cash equivalents. Kinder Morgan’s net debt stood at $32.03 billion at quarter-end. The net debt-to-adjusted EBITDA ratio improved to 3.6X from 3.8X at the end of 2025. |
|||
|
Saved
2026-07-24 15:14
2d ago
Published
2026-07-24 12:05
2d ago
|
Russian Experts Split on EU’s New Crypto Sanctions: Adapt or Isolate? | CoinGecko News | |
|
Original source text
Russian Experts Split on EU’s New Crypto Sanctions: Adapt or Isolate? |
|||
|
Saved
2026-07-24 15:14
2d ago
Published
2026-07-24 10:56
2d ago
|
Wall Street Analysts Think Elastic (ESTC) Could Surge 26.29%: Read This Before Placing a Bet | FMP Stock News | |
|
Original source text
Shares of Elastic (ESTC - Free Report) have gained 7% over the past four weeks to close the last trading session at $57.33, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $72.4 indicates a potential upside of 26.3%.The mean estimate comprises 25 short-term price targets with a standard deviation of $13.37. While the lowest estimate of $55.00 indicates a 4.1% decline from the current price level, the most optimistic analyst expects the stock to surge 84.9% to reach $106.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable. But, for ESTC, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside. Price, Consensus and EPS Surprise Here's What You Should Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading. While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why? They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts. However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces. That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism. Why ESTC Could Witness a Solid UpsideAnalysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason to expect an upside in the stock. That's because empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For the current year, one estimate has moved higher over the last 30 days compared to no negative revision. As a result, the Zacks Consensus Estimate has increased 13.5%. Moreover, ESTC currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> . Therefore, while the consensus price target may not be a reliable indicator of how much ESTC could gain, the direction of price movement it implies does appear to be a good guide. |
|||
|
Saved
2026-07-24 15:13
2d ago
Published
2026-07-24 11:01
2d ago
|
Ares Management (ARES) Earnings Expected to Grow: What to Know Ahead of Next Week's Release | FMP Stock News | |
|
Original source text
The market expects Ares Management (ARES - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. Zacks Consensus EstimateThis private equity firm is expected to post quarterly earnings of $1.29 per share in its upcoming report, which represents a year-over-year change of +25.2%. Revenues are expected to be $1.32 billion, up 25.6% from the year-ago quarter. Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.38% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS Surprise Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction). The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). How Have the Numbers Shaped Up for Ares Management?For Ares Management, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +1.48%. On the other hand, the stock currently carries a Zacks Rank of #4. So, this combination makes it difficult to conclusively predict that Ares Management will beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Ares Management would post earnings of $1.32 per share when it actually produced earnings of $1.24, delivering a surprise of -6.06%. Over the last four quarters, the company has beaten consensus EPS estimates just once. Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Ares Management doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. An Industry Player's Expected ResultsAmong the stocks in the Zacks Financial - Investment Management industry, KKR & Co. Inc. (KKR - Free Report) , is soon expected to post earnings of $1.42 per share for the quarter ended June 2026. This estimate indicates a year-over-year change of +20.3%. This quarter's revenue is expected to be $1.52 billion, up 18.5% from the year-ago quarter. The consensus EPS estimate for KKR & Co. has been revised 0.2% higher over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +0.18%. When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that KKR & Co. will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. |
|||
|
Saved
2026-07-24 15:13
2d ago
Published
2026-07-24 10:18
2d ago
|
MaxLinear Analysts Boost Their Forecasts After Upbeat Q2 Results | FMP Stock News | |
|
Original source text
MaxLinear Inc. (NASDAQ:MXL) on Thursday reported upbeat second-quarter earnings and issued strong third-quarter guidance.Second-quarter revenue rose 55% year over year and 23% sequentially to $168.8 million, beating the $164.702 million analyst estimate. GAAP earnings were 2 cents per share, while adjusted earnings of 35 cents per share topped the 33-cent estimate. “Our Q2 financial results highlight the exciting inflection in our business trajectory and the beginning of a multiyear growth phase for MaxLinear,” CEO Kishore Seendripu said. For the third quarter, MaxLinear expects revenue of $210 million to $220 million, above the $173.837 million analyst estimate. MaxLinear shares dipped 14.6% to trade at $77.90 on Friday. These analysts made changes to their price targets on MaxLinear following earnings announcement. Needham analyst N. Quinn Bolton maintained the stock with a Buy and raised the price target from $60 to $100. Susquehanna analyst Christopher Rolland maintained the stock with a Neutral and raised the price target from $45 to $80. Considering buying MXL stock? Here’s what analysts think: Photo via Shutterstock Market News and Data brought to you by Benzinga APIs © 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. To add Benzinga News as your preferred source on Google, click here. |
|||
|
Saved
2026-07-24 15:13
2d ago
Published
2026-07-24 11:01
2d ago
|
MXL Q2 Earnings Call Highlights Optical AI Data Center Growth | FMP Stock News | |
|
Original source text
Key Takeaways MaxLinear's infrastructure revenues rose 145% year over year, led by optical data center product ramps.MXL raised 2026 optical data center revenue outlook to $210-$230 million on stronger orders.Rushmore, Washington and Annapurna platforms are aimed at future AI connectivity applications. MaxLinear, Inc. (MXL - Free Report) used its second-quarter 2026 earnings call to highlight accelerating momentum in optical AI data center products, with management pointing to stronger demand, expanding customer engagements and a broader infrastructure portfolio.The company raised expectations for optical data center revenue while outlining new product ramps aimed at future AI infrastructure architectures. Management also discussed improving profitability and operating leverage. MXL Drives Optical ExpansionCEO Kishore Seendripu said MaxLinear’s infrastructure business has become the company’s largest revenue category, driven by production ramps of optical data center products. Infrastructure revenues increased 145% year over year in the second quarter. Seendripu highlighted the Keystone PAM4 DSP platform as a key growth driver, with the product supporting 400G and 800G optical deployments at major hyperscale customers. He noted that Keystone’s power performance has helped support customer adoption. The company raised its 2026 optical data center revenue outlook to $210 million to $230 million, citing stronger customer orders and improved visibility into production ramps. MaxLinear Expands AI Connectivity RoadmapMaxLinear discussed several products positioned for future AI infrastructure needs, including Rushmore, Washington and Annapurna. Management said these platforms are designed for higher-speed optical and electrical connectivity applications. Seendripu said Rushmore, a 1.6-terabit optical PAM4 DSP platform, is expected to begin contributing revenues in 2027. The company also expects Washington and Annapurna products to begin initial revenue contributions in 2027 before broader ramps. The broader portfolio expansion includes solutions targeting pluggable optics, LPO, LRO, NPO, CPO and active electrical cable applications, giving MaxLinear additional exposure to evolving AI data center architectures. MXL Raises Growth ExpectationsMaxLinear reported second-quarter revenues of $168.8 million, up 55% year over year and 23% sequentially. Revenues beat the Zacks Consensus Estimate of $165 million. Non-GAAP EPS was 35 cents, ahead of the Zacks Consensus Estimate of 33 cents. Chief financial officer Steven Litchfield said the company’s infrastructure mix helped drive higher profitability. Non-GAAP gross margin was 59.5%, while non-GAAP operating margin reached 22.3%. For the third quarter of 2026, MaxLinear guided revenues of $210 million to $220 million. It expects non-GAAP gross margin of 58.5% to 61.5%. MaxLinear Builds Broader Market ReachManagement said broadband and connectivity markets also delivered growth during the quarter. The company cited deployments of fiber PON and Wi-Fi 7 gateway platforms with major service providers. Litchfield said MaxLinear continues to gain share in PON programs and expects broadband activity to remain supported by customer rollouts. He added that DOCSIS upgrades are also progressing. Outside data centers, the company highlighted opportunities in edge AI-driven upgrades, 5G wireless infrastructure and storage acceleration products. MXL Addresses Analyst QuestionsA Stifel analyst asked about the increase in optical revenue expectations and the drivers behind the stronger outlook. Management said growth is increasingly coming from 800G PAM4 adoption, with customer activity spanning U.S. and Asia markets. A Benchmark analyst questioned order visibility and supply commitments. Litchfield said visibility extends about six months and that wafer prepayments are supporting customer demand backed by production needs. A Needham analyst asked about Rushmore qualification activity. Seendripu said Keystone has established a customer foundation that can support future 1.6-terabit product adoption. MaxLinear Focuses on ProfitabilityMaxLinear management emphasized improving operating leverage as infrastructure revenues grow. Litchfield said the company remains focused on progressing toward its long-term goal of 30% to 35% operating margins. The company ended the quarter with $93.7 million in cash, cash equivalents and restricted cash, while operating cash flow was approximately $4.8 million. Management’s outlook centered on continued product ramps, higher-speed connectivity opportunities and expanding participation in AI infrastructure markets over the next several years. Zacks Rank & Style ScoresMaxLinear currently carries a Zacks Rank #3 (Hold). The Zacks Rank focuses on earnings estimate revisions and is designed to help indicate stocks with stronger potential performance over a one-to-three-month period. The rank can change as analysts update earnings estimates following new company information. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The company has a Value Score of F, Growth Score of A, Momentum Score of F and VGM Score of C. Zacks Style Scores range from A to F, with stronger scores reflecting more favorable characteristics for the related investment style. The Style Scores are intended to complement the Zacks Rank. Zacks notes that stocks with stronger Rank combinations and favorable Style Scores have historically shown better performance characteristics, while individual scores should be viewed alongside the broader Zacks Rank framework. |
|||
|
Saved
2026-07-24 15:12
2d ago
Published
2026-07-24 09:56
2d ago
|
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar | FMP Stock News | |
|
Original source text
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among the rest: earnings.Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises. The ability to identify stocks that are likely to top quarterly earnings expectations can be profitable, but it's no simple task. Here at Zacks, our Earnings ESP filter helps make things easier. The Zacks Earnings ESP, ExplainedThe Zacks Expected Surprise Prediction, or ESP, works by locking in on the most up-to-date analyst earnings revisions because they can be more accurate than estimates from weeks or even months before the actual release date. The thinking is pretty straightforward: analysts who provide earnings estimates closer to the report are likely to have more information. Now that we understand the basic idea, let's look at how the Expected Surprise Prediction works. The ESP is calculated by comparing the Most Accurate Estimate to the Zacks Consensus Estimate, with the percentage difference between the two giving us the Zacks ESP figure. When we join a positive earnings ESP with a Zacks Rank #3 (Hold) or stronger, stocks posted a positive bottom-line surprise 70% of the time. Plus, this system saw investors produce roughly 28% annual returns on average, according to our 10 year backtest. Most stocks, about 60%, fall into the #3 (Hold) category, and they are expected to perform in-line with the broader market. Stocks with a #2 (Buy) and #1 (Strong Buy) rating, or the top 15% and top 5% of stocks, respectively, should outperform the market, with Strong Buy stocks outperforming more than any other rank. Should You Consider Teradyne?Now that we understand what the ESP is and how beneficial it can be, let's dive into a stock that currently fits the bill. Teradyne (TER - Free Report) earns a #2 (Buy) right now and its Most Accurate Estimate sits at $2.05 a share, just four days from its upcoming earnings release on July 28, 2026. TER has an Earnings ESP figure of +0.59%, which, as explained above, is calculated by taking the percentage difference between the $2.05 Most Accurate Estimate and the Zacks Consensus Estimate of $2.04. Teradyne is one of a large database of stocks with positive ESPs. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. TER is one of just a large database of Computer and Technology stocks with positive ESPs. Another solid-looking stock is Lam Research (LRCX - Free Report) . Slated to report earnings on July 29, 2026, Lam Research holds a #2 (Buy) ranking on the Zacks Rank, and its Most Accurate Estimate is $1.71 a share five days from its next quarterly update. For Lam Research, the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of $1.69 is +1.38%. TER and LRCX's positive ESP metrics may signal that a positive earnings surprise for both stocks is on the horizon. Find Stocks to Buy or Sell Before They're ReportedUse the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >> |
|||
|
Saved
2026-07-24 15:12
2d ago
Published
2026-07-24 08:38
2d ago
|
These Analysts Slash Their Forecasts On Deckers Outdoor Following Q1 Results | FMP Stock News | |
|
Original source text
Deckers Outdoor Corp (NYSE:DECK) on Thursday reported upbeat first-quarter financial results.Deckers Outdoor reported quarterly earnings of 94 cents per share, which beat the analyst consensus estimate of 87 cents by 8.05%, according to Benzinga Pro data. Quarterly revenue came in at $1.02 billion, which beat the analyst consensus estimate of $1.018 billion. "Deckers delivered a solid start to the fiscal year, surpassing $1 billion of first quarter revenue for the first time," said CEO Stefano Caroti. Deckers Outdoor shares fell 2.4% to $93.91 in pre-market trading. These analysts made changes to their price targets on Intel following earnings announcement. Baird analyst Jonathan Komp maintained the stock with a Neutral and lowered the price target from $125 to $115. Needham analyst Tom Nikic maintained the stock with a Buy and lowered the price target from $138 to $125. Considering buying DECK stock? Here’s what analysts think: Photo via Shutterstock Market News and Data brought to you by Benzinga APIs © 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. To add Benzinga News as your preferred source on Google, click here. |
|||
|
Saved
2026-07-24 15:12
2d ago
Published
2026-07-24 10:16
2d ago
|
Deckers Stock Down 6% Despite Q1 Earnings Beat, FY'27 Outlook Raised | FMP Stock News | |
|
Original source text
Key Takeaways Deckers beat Q1 earnings and revenue estimates, driven by HOKA, UGG and strong DTC demand.DECK raised fiscal 2027 EPS guidance but increased its forward tariff cost assumption to 12.5%.Deckers expects Q2 gross margin pressure from higher tariff and freight costs, despite healthy demand. Deckers Outdoor Corporation (DECK - Free Report) reported first-quarter fiscal 2027 results, with both earnings and revenues surpassing the Zacks Consensus Estimate. The company reported earnings of 94 cents per share, up 1.1% year over year, which beat the Zacks Consensus Estimate of 88 cents by 6.8%. Net sales increased 5.7% year over year to $1,019.5 million and topped the consensus estimate of $1,017 million by 0.3%. On a constant-currency basis, net sales grew 4.8% year over year.The company delivered its first-ever June quarter with more than $1 billion in revenues, driven by continued momentum in the HOKA and UGG brands, strong direct-to-consumer (DTC) demand and disciplined full-price selling across channels. Management also raised its fiscal 2027 earnings outlook following stronger-than-expected first-quarter profitability. However, investors remained cautious as the company projected lower second-quarter gross margin due to tariff and freight headwinds, and increased its tariff cost assumption for the remainder of fiscal 2027. Consequently, shares of the company lost 6.1% yesterday. DECK’s Brand Momentum Led by HOKA & UGGThe HOKA brand remained the primary growth driver in the first quarter, with net sales increasing 7.7% year over year to $703.5 million, slightly missing our estimate of $705.3 million. Growth was driven by a 17% increase in DTC revenues, supported by continued strength in Europe, China, Japan and the United States. Management highlighted broad-based demand across franchise families, with Clifton, Bondi, Speedgoat 7, Mach 7, Mafate Speed 2 and Skyward contributing to growth. The company also noted encouraging early consumer response to the recently launched Clifton Pro, while healthy full-price selling and disciplined marketplace management continued to support the brand's performance. The UGG brand delivered solid first-quarter results, with net sales increasing 4.9% year over year to $278 million, beating our estimate of $276.2 million. Growth was balanced across wholesale and DTC channels, with international markets, particularly Asia, leading performance. Management highlighted continued progress in its 365 and men's growth initiatives, supported by strong demand for the Lowmel family, Golden collection and Otzo Clog. The company cited encouraging consumer response to its spring apparel collection, particularly fleece products, reinforcing UGG's expansion as a year-round lifestyle brand. Meanwhile, net sales from Other Brands declined 18.1% year over year to $37.9 million compared with our estimate of $37.5 million, primarily reflecting the continued phase-out of Koolaburra standalone operations. Deckers’ DTC & International Businesses Drive Q1 GrowthWholesale net sales increased 2.2% year over year to $666.7 million in the first quarter. Reported wholesale growth reflected planned timing differences that shifted certain international wholesale and distributor shipments to later in fiscal 2027 compared with the prior year. Management emphasized that underlying demand remained healthy, supported by higher U.S. wholesale sell-in, strong full-price sell-through and record reorder activity in the EMEA region. DTC net sales increased 13% year over year to $352.8 million, while comparable DTC sales rose 6.8%, driven by continued strength across both HOKA and UGG. HOKA's international DTC business continued to post robust growth in Europe, China and Japan. From a geographic perspective, domestic net sales increased 3.2% year over year to $517.4 million. International net sales rose 8.4% to $502.1 million. Management noted that both HOKA and UGG continued to generate healthy demand across international markets, with Europe, China and Japan remaining key contributors to growth. DECK’s Full-Price Selling Lifts Gross MarginGross profit increased 6.9% year over year to $575.2 million in the first quarter. Gross margin expanded 60 basis points to 56.4% and surpassed our estimate of 54.6%. Favorable channel and product mix, full-price selling, foreign exchange benefits and better management of closeout inventory more than offset a 150-basis-point tariff headwind. Closeout management contributed about 60 basis points to the year-over-year margin comparison. Selling, general and administrative expenses increased 12.7% year over year to $419.9 million. As a percentage of net sales, SG&A expenses increased to 41.2% from 38.6% in the prior-year quarter. Higher spending reflected continued investments in marketing, technology, additional personnel supporting key growth initiatives, higher occupancy costs related to new HOKA stores and unfavorable foreign currency remeasurement. Operating income declined 6% year over year to $155.3 million from $165.3 million in the year-ago quarter. The operating margin contracted to 15.2% from 17.1%. DECK Maintains Strong Liquidity & Shareholder ReturnsCash and cash equivalents were $1.60 billion as of June 30, 2026, compared with $1.72 billion a year earlier. Inventories declined 4.9% year over year to $807.6 million, and the company maintained a debt-free balance sheet with no outstanding borrowings. Total stockholders' equity stood at $2.30 billion at the end of the quarter. During the first quarter of fiscal 2027, Deckers repurchased approximately 3.3 million shares of its common stock for $338.2 million at an average price of $103.79 per share. The company noted that share repurchases continued to be an important component of its capital allocation strategy. As of June 30, 2026, approximately $4.7 billion remained available under the company's existing share repurchase authorization. Q2’27 Outlook for DECKFor the fiscal second quarter, this Zacks Rank #2 (Buy) company expects consolidated revenues to increase approximately 5% year over year. HOKA revenues are projected to grow at a high-single-digit rate, while UGG is expected to maintain its mid-single-digit growth rate. Other Brands revenues are expected to decline approximately 50% from the prior-year quarter, primarily reflecting the continued streamlining of the company's brand portfolio following the wind-down of the Koolaburra business. Management indicated that second-quarter results will continue to reflect planned timing differences in the wholesale and distributor businesses, with some international shipments moving later into the fiscal year. Similar to the first quarter, these timing dynamics are expected to affect reported wholesale growth but do not reflect any change in underlying consumer demand. The company expects continued strength in its direct-to-consumer business, while emphasizing that HOKA and UGG will continue to experience healthy demand across regions and channels. Gross margin is expected to decline year over year due to higher tariff costs and rising freight expenses. Selling, general and administrative expenses will remain elevated as the company continues to make first-half weighted investments in its strategic growth initiatives, including brand-building, technology and marketplace expansion. As a result, earnings per share are expected to be in the range of $1.73-$1.78. Management also reiterated that revenue growth is expected to accelerate in the second half of fiscal 2027, primarily driven by the HOKA brand and the normalization of international wholesale and distributor shipment timing. The company noted that quarterly growth is not expected to be linear as it continues to prioritize a pull model of demand and disciplined marketplace execution to support long-term sustainable growth. Deckers’ Fiscal 2027 View Reflects Higher Tariff AssumptionsFor fiscal 2027, Deckers continues to expect consolidated net sales to be in the range of $5.86-$5.91 billion, representing high-single-digit growth from the prior year. HOKA revenues are still expected to increase at a low-double-digit rate, while UGG revenues are projected to grow at a mid-single-digit pace. Management continues to expect revenue growth to accelerate in the second half of fiscal 2027, primarily driven by the HOKA brand and the normalization of international wholesale and distributor shipment timing. The company now expects gross margin to be slightly better than 56.5%, reflecting stronger-than-expected first-quarter performance. The updated outlook incorporates a higher forward tariff assumption of 12.5%, up from the previous 10% and continues to exclude any benefit from potential refunds of tariffs previously paid. Management indicated that it is pursuing tariff refunds but has not included any related assumptions in its fiscal 2027 guidance given the uncertainty around timing and recovery. Selling, general and administrative expenses are still expected to be approximately 35% of net sales as Deckers continues investing in its long-term growth initiatives. Planned investments remain focused on strengthening the company's brand portfolio through marketing, expanding technology capabilities and data analytics, supporting key growth initiatives and reinforcing the foundation of the business. Management stated that these investments are intended to position the company for operating expense leverage beginning in fiscal 2028 and beyond. Operating margin is now anticipated to be slightly better than 21.5%, reflecting the improved gross margin outlook. The company continues to project an effective tax rate of approximately 23% and has raised its fiscal 2027 earnings per share guidance to $7.35-$7.50, as compared with its prior outlook of $7.30-$7.45, driven by higher expected gross margin. The guidance also assumes share repurchases with a value equal to approximately 80% of projected fiscal 2027 free cash flow. DECK Stock Past Three-Month Performance Image Source: Zacks Investment Research Shares of the company have lost 9.9% over the past three months compared with the industry’s 1.2% decline. Other Key Retail PicksGenesco Inc. (GCO - Free Report) is a Nashville-based specialty retailer and branded company. It sells footwear and accessories through retail stores. The company flaunts a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for Genesco’s current fiscal-year earnings indicates growth of 55.2% from the year-ago actuals. GCO delivered a trailing four-quarter average earnings surprise of 3.8%. Canada Goose (GOOS - Free Report) is a designer, manufacturer, distributor and retailer of premium outerwear for men, women and children. The company also holds a Zacks Rank #1 at present. The Zacks Consensus Estimate for Canada Goose’s current fiscal-year earnings and sales indicates growth of 58.9% and 3.7%, respectively, from the year-ago actuals. GOOS delivered a negative trailing four-quarter average earnings surprise of 43.3%. Designer Brands Inc. (DBI - Free Report) designs, produces and retails footwear and accessories. It offers shoes, boots, sandals, sneakers, socks, handbags and accessories. It currently carries a Zacks Rank #2. The Zacks Consensus Estimate for Designer Brands’ current fiscal-year earnings and sales suggests growth of 137.5% and 0.5%, respectively, from the year-ago actuals. DBI delivered a trailing four-quarter average earnings surprise of 112.8%. |
|||
|
Saved
2026-07-24 15:12
2d ago
Published
2026-07-24 10:30
2d ago
|
Friday's Morning Movers: DECK, VZ & CHTR Earnings | FMP Stock News | |
|
Original source text
It's all about earnings to kick off the final trading session of the week. Sam Vadas explains why an increase in Hoka sales and a full-year EPS guidance raise wasn't enough for Deckers Brands (DECK). |
|||
|
Saved
2026-07-24 15:12
2d ago
Published
2026-07-24 10:46
2d ago
|
Why Deckers (DECK) is a Top Growth Stock for the Long-Term | FMP Stock News | |
|
Original source text
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days. Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform. The Style Scores are broken down into four categories: Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks. Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time. Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates. VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum. How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier. It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day. But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from. That's where the Style Scores come in. To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible. The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank. Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too. Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Stock to Watch: Deckers (DECK - Free Report) Founded in 1973 and headquartered in Goleta, Deckers Outdoor Corp. is a leading designer, producer and brand manager of innovative footwear, apparel and accessories developed for outdoor sports, high-performance activities and lifestyle use. The company sells products primarily under three proprietary brands — UGG, HOKA and Other brands (primarily comprised of Teva). DECK is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. Additionally, the company could be a top pick for growth investors. DECK has a Growth Style Score of A, forecasting year-over-year earnings growth of 6.3% for the current fiscal year. Two analysts revised their earnings estimate higher in the last 60 days for fiscal 2027, while the Zacks Consensus Estimate has increased $0.04 to $7.46 per share. DECK also boasts an average earnings surprise of +15.2%. With a solid Zacks Rank and top-tier Growth and VGM Style Scores, DECK should be on investors' short list. |
|||
|
Saved
2026-07-24 15:12
2d ago
Published
2026-07-24 09:00
2d ago
|
Green Plains to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026 | FMP Stock News | |
|
Original source text
OMAHA, Neb.--(BUSINESS WIRE)--Green Plains Inc. (NASDAQ:GPRE) will release second quarter 2026 financial results prior to the market opening on August 6, 2026, and then host a conference call beginning at 9 a.m. Eastern time (8 a.m. Central time) to discuss the results and outlook. Domestic and international participants can access the conference call by dialing 833.461.5787 and 585.542.9983, respectively, and referencing conference ID 249495185. Participants are advised to call at least 10 min. |
|||
|
Saved
2026-07-24 15:11
2d ago
Published
2026-07-24 10:41
2d ago
|
Sensata (ST) is a Top-Ranked Value Stock: Should You Buy? | FMP Stock News | |
|
Original source text
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days. Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on. The Style Scores are broken down into four categories: Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks. Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time. Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks. VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum. How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio. #1 (Strong Buy) stocks have produced an unmatched +23.94% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day. With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey. That's where the Style Scores come in. You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible. The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank. Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too. Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Stock to Watch: Sensata (ST - Free Report) Headquartered in Attleboro, MA, Sensata Technologies is a global industrial technology company that develops, manufactures and sells sensors and sensor-rich solutions as well as electrical protection components and systems. ST is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 12.23; value investors should take notice. For fiscal 2026, one analyst revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.00 to $3.73 per share. ST boasts an average earnings surprise of +3.3%. With a solid Zacks Rank and top-tier Value and VGM Style Scores, ST should be on investors' short list. |
|||
|
Saved
2026-07-24 15:10
2d ago
Published
2026-07-24 09:36
2d ago
|
Implied Volatility Surging for Grocery Outlet Stock Options | FMP Stock News | |
|
Original source text
Investors in Grocery Outlet Holding Corp. (GO - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug. 21, 2026 $1.00 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy. What do the Analysts Think?Clearly, options traders are pricing in a big move for Grocery Outlet shares, but what is the fundamental picture for the company? Currently, Grocery Outlet is a Zacks Rank #3 (Hold) in the Consumer Products - Staples industry that ranks in the Bottom 23% of our Zacks Industry Rank. Over the last 60 days, no analysts have increased their earnings estimates for the to-be-reported quarter, while one analyst has revised the estimate downward. The net effect has taken our Zacks Consensus Estimate for the to-be-reported quarter from 13 cents per share to 12 cents in that period. Given the way analysts feel about Grocery Outlet right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected. |
|||
|
Saved
2026-07-24 15:10
2d ago
Published
2026-07-24 11:01
2d ago
|
Church & Dwight (CHD) Expected to Beat Earnings Estimates: Should You Buy? | FMP Stock News | |
|
Original source text
The market expects Church & Dwight (CHD - Free Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise. Zacks Consensus EstimateThis maker of household and personal products is expected to post quarterly earnings of $0.89 per share in its upcoming report, which represents a year-over-year change of -5.3%. Revenues are expected to be $1.5 billion, down 0.2% from the year-ago quarter. Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.27% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS Surprise Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). How Have the Numbers Shaped Up for Church & Dwight?For Church & Dwight, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.65%. On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination indicates that Church & Dwight will most likely beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Church & Dwight would post earnings of $0.93 per share when it actually produced earnings of $0.95, delivering a surprise of +2.15%. Over the last four quarters, the company has beaten consensus EPS estimates four times. Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Church & Dwight appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. |
|||
|
Saved
2026-07-24 15:09
2d ago
Published
2026-07-24 09:44
2d ago
|
PLNT CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Planet Fitness Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 | FMP Stock News | |
|
Original source text
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Planet Fitness To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Planet Fitness between November 6, 2025, and May 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Planet Fitness, Inc. (""Planet Fitness" or the "Company") (NYSE: PLNT) and reminds investors of the September 14, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose facts concerning the true state of Planet Fitness' customer acquisition and marketing metrics. Notably, the Company's updated marketing messaging was failing to resonate with, and was actively intimidating, its core target demographic of fitness beginners and casual gym-goers. As a result, Planet Fitness was experiencing a significant headwind in net member joins during its peak first-quarter sign-up period that rendered its previously issued fiscal 2026 guidance and long term financial targets unachievable. On May 7, 2026, Planet Fitness announced its first quarter results for fiscal 2026, revealing that its critical peak sign-up period was off to a slower-than-expected start internally, slashing same-store growth guidance from 4-5% to only 1%, completely withdrawing its long-term three-year growth algorithm, and announcing a pause of the planned national rollout of the Black Card price increase. On this news, Planet Fitness's stock price fell $19.95, or 31.19%, to close at $44.01 per share on May 7, 2026. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Planet Fitness's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Planet Fitness class action, go to www.faruqilaw.com/PLNT or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Frequently Asked Questions (FAQ) for Investors Regarding the Planet Fitness Securities Class Action Lawsuit: What is the Planet Fitness securities fraud lawsuit about? This securities class action lawsuit alleges that Planet Fitness, Inc. made materially false and misleading statements and/or concealed material adverse facts during the class period concerning the company's customer acquisition and marketing metrics. Specifically, the complaint alleges that Planet Fitness's updated marketing messaging was failing to resonate with - and was allegedly actively intimidating - its core target demographic of fitness beginners and casual gym-goers. As a result, the company allegedly experienced a significant headwind in net member joins during its critical peak first-quarter sign-up period, rendering its previously issued fiscal 2026 guidance and long-term financial targets unachievable. On May 7, 2026, Planet Fitness announced its first quarter fiscal 2026 results, at which time it slashed same-store growth guidance from 4-5% to only 1%, completely withdrew its long-term three-year growth algorithm, and announced a pause of the planned national rollout of its Black Card price increase. On that news, Planet Fitness's stock price fell $19.95 per share, or approximately 31.19%, to close at $44.01 per share on May 7, 2026. Who may be eligible to participate in the lawsuit? Investors who purchased or otherwise acquired Planet Fitness, Inc. common stock traded on the NASDAQ under the ticker symbol PLNT between November 6, 2025 and May 6, 2026, inclusive, may be eligible to participate in this lawsuit. Eligibility to participate in any potential recovery is not limited to investors who seek appointment as lead plaintiff; any class member who suffered losses during the class period may be entitled to share in any recovery that may be obtained. Investors are encouraged to review their trading records to determine whether their purchases fall within the applicable class period. Additional information about eligibility may be obtained by contacting Faruqi & Faruqi, LLP. What is a lead plaintiff, and how can I seek appointment? A lead plaintiff is a court-appointed representative who serves on behalf of all class members and plays an active role in directing the litigation, including working with counsel on case strategy and settlement negotiations. The lead plaintiff is typically the class member who suffered the largest financial loss and who satisfies certain adequacy and typicality requirements under the Private Securities Litigation Reform Act of 1995. Investors who wish to seek appointment as lead plaintiff must file a motion with the court no later than September 14, 2026. Importantly, investors do not need to serve as lead plaintiff in order to participate in the lawsuit or share in any recovery that may be obtained - class membership alone may entitle eligible investors to a portion of any proceeds. What should investors do if they purchased Planet Fitness stock during the Class Period? Investors who purchased Planet Fitness, Inc. common stock on the NASDAQ (PLNT) during the class period from November 6, 2025 through May 6, 2026 are encouraged to review their brokerage and trading records to confirm the timing and details of their purchases. Investors should take steps to preserve all relevant documentation, including trade confirmations, account statements, and any communications related to their Planet Fitness holdings, as such records may be important to establishing their claims. Given that the lead plaintiff motion deadline is September 14, 2026, investors who wish to be considered for appointment as lead plaintiff should act promptly. Investors may wish to consult with Faruqi & Faruqi, LLP prior to that deadline to evaluate their legal options and understand their rights, even if they do not intend to seek the lead plaintiff role. Why should investors contact Faruqi & Faruqi, LLP? Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Planet Fitness securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306262 Source: Faruqi & Faruqi LLP Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs. Contact Us |
|||
|
Saved
2026-07-24 15:09
2d ago
Published
2026-07-24 10:32
2d ago
|
PLNT Investors Have Opportunity to Lead Planet Fitness, Inc. Securities Fraud Lawsuit with the Schall Law Firm | FMP Stock News | |
|
Original source text
LOS ANGELES, July 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Planet Fitness, Inc. (“Planet Fitness” or “the Company”) (NYSE: PLNT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company’s securities between November 6, 2025 and May 6, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before September 14, 2026. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected]. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Planet Fitness failed to effectively roll out a national price increase on its Black Card offering. The Company overstated its growth outlook. The Company exaggerated its ability to drive new member joins with its existing market campaign. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Planet Fitness, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: The Schall Law Firm Brian Schall, Esq., www.schallfirm.com Office: 310-301-3335 [email protected] SOURCE: The Schall Law Firm |
|||
|
Saved
2026-07-24 15:09
2d ago
Published
2026-07-24 11:06
2d ago
|
Eastern Bankshares Q2 Earnings Call Highlights | FMP Stock News | |
|
Original source text
Eastern Bankshares NASDAQ: EBC reported record operating net income for the second quarter, supported by loan and deposit growth, margin expansion, higher fee revenue and expense reductions tied to the HarborOne integration.Chief Executive Officer Denis Sheahan said operating net income increased 20% from the prior quarter and 30% from a year earlier, producing an operating return on average tangible common equity of 15.3%. The company also returned $106 million to shareholders through dividends and share repurchases during the quarter. Get Eastern Bankshares alerts: “Our results are a reflection of the priorities we have consistently communicated to investors, organically growing both banking and fee-based businesses and returning capital to shareholders,” Sheahan said. Second-Quarter Results and Margin Trends Eastern reported GAAP net income of $105.2 million, or $0.48 per diluted share. Operating net income, which excluded $1.6 million of remaining HarborOne merger-related costs, was $106.5 million, or $0.49 per diluted share. Chief Financial Officer David Rosato said operating revenue growth and expense management generated positive operating leverage. The operating efficiency ratio improved to 49%, while operating return on average assets increased 21 basis points to 1.38%. Net interest income increased 3% from the first quarter as the net interest margin expanded 3 basis points to 3.66%. Higher yields on loans and securities more than offset increased funding costs, Rosato said. Total interest-earning asset yields rose 4 basis points, while interest-bearing liability costs increased 2 basis points. Discount accretion remained about $20 million during the quarter and contributed 28 basis points to the margin. Rosato later said the company expects accretion income to remain around its recent quarterly run rate of roughly $19.5 million, with a potential slight decline over time. Operating non-interest income rose $12.8 million, or 28%, from the first quarter. The largest contributor was an $8.9 million increase in investment income related to employee retirement benefits, reflecting stronger equity markets. That gain was partly offset by a $3.4 million increase in related employee benefit costs. The company also cited higher investment advisory fees, seasonal tax preparation fees and increased interest-rate swap income. Rosato said swap income benefited from higher commercial loan volume and greater customer use of interest-rate risk-management products. Loan, Deposit and Wealth Management Growth Period-end loan balances increased $325 million, or 1.4%, from the preceding quarter. More than $300 million of commercial and industrial loan growth drove the increase, partially offset by commercial real estate payoffs. Sheahan said the commercial lending pipeline finished June at a record level and was diversified across businesses. Rosato put the commercial pipeline at nearly $1 billion. Management said it expects commercial real estate payoffs, which were elevated in the second quarter, to moderate during the second half of the year. Home equity balances rose $59 million, while residential mortgage balances declined slightly. Rosato said Eastern expects its residential mortgage portfolio to remain relatively flat in 2026 as it emphasizes home equity and commercial lending growth. Deposits increased $814 million, or 3.2%, from the prior quarter, driven by seasonal municipal inflows and broad-based growth across business lines. The loan-to-deposit ratio improved to 91% at quarter-end from 93% at March 31. Management expects a portion of municipal deposits to leave seasonally in the third quarter. Total deposit costs increased 1 basis point to 1.47%, while the June spot deposit rate was 1.51%, reflecting competition in the New England deposit market. Rosato said competition remains relatively constant and does not expect it to ease in the near term. The company expects money market balances to grow faster than certificates of deposit, citing customer preference for money market products. Wealth management assets reached a record $11.5 billion. Sheahan said the business provides recurring fee income, diversifies earnings and deepens customer relationships, particularly through coordination among wealth management, private banking and commercial banking teams. Credit Quality, Costs and Capital Return Asset quality remained strong, according to management. Net charge-offs were stable at 17 basis points of average total loans. Nonperforming loans declined $29 million from the first quarter to $109 million, or 47 basis points of total loans. Sheahan said Eastern has limited exposure to life-science lending and continues to monitor its office portfolio closely. He said every office loan above $5 million is re-underwritten annually. Non-interest expense declined $30.7 million, or 15%, from the first quarter. Most of the reduction reflected lower merger-related costs, while operating non-interest expense declined $1.5 million. Rosato said HarborOne cost savings are “basically done,” with savings primarily reflected in salaries and benefits as well as occupancy and equipment costs. Eastern paid $33.1 million in dividends and repurchased 3.6 million shares for $72.7 million during the quarter, at an average price of $20.03 per share. Its CET1 ratio was 13% and its tangible common equity ratio was 10.1% at June 30. The board authorized a new repurchase program for up to 11.3 million shares, equivalent to 5% of common shares outstanding, through Dec. 31, 2027. The board also approved a $0.15 per-share dividend payable in September. Updated 2026 Outlook Eastern narrowed its full-year loan growth outlook to 3% to 4%, from a previous range of 3% to 5%, reflecting a slower start to the year. It raised its deposit growth outlook to 2% to 3%, from 1% to 2%. The company also lowered its outlook for net interest income and margin, citing softer first-quarter loan growth, lower-than-expected accretion income and deposit competition. Management expects full-year fully taxable equivalent net interest margin of 3.60% to 3.65%. Eastern reduced its expected provision for credit losses to $25 million to $30 million, from $30 million to $40 million, citing favorable credit performance. It narrowed its operating fee income outlook to $195 million to $200 million and tightened its operating non-interest expense range to $655 million to $665 million. About Eastern Bankshares (NASDAQ:EBC)Eastern Bankshares, Inc is the bank holding company for Eastern Bank, one of the oldest and largest mutual banks in the United States. Founded in 1818 as Salem Savings Bank and later rebranded as Eastern Bank in 1989, the company preserved its mutual ownership structure for more than two centuries. In March 2020, it completed an initial public offering and began trading on the Nasdaq under the ticker EBC, while continuing to emphasize its community-focused heritage. Through its primary subsidiary, Eastern Bank, the company delivers a broad range of commercial and consumer banking products. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Should You Invest $1,000 in Eastern Bankshares Right Now?Before you consider Eastern Bankshares, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastern Bankshares wasn't on the list. While Eastern Bankshares currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom. Get This Free Report |
|||
|
Saved
2026-07-24 15:09
2d ago
Published
2026-07-24 10:50
2d ago
|
Goosehead Insurance: Strong Q2, But The Valuation Leaves Little Room For Error | FMP Stock News | |
|
Original source text
HomeEarnings AnalysisFinancials SummaryGoosehead Insurance delivered 20% year-over-year revenue growth in Q2 2026, with $113.4 million in revenues and 86% client retention.GSHD's dual distribution model leverages a growing franchise network and technology platforms, supporting scalable premium growth with limited capital intensity.The company trades at a forward P/E of 36.7x, reflecting high-growth expectations but exposing investors to valuation risk if growth or retention falters.Revenue concentration in homeowners and auto insurance and sensitivity to real estate and insurer risk appetite present structural risks to GSHD's outlook. seb_ra/iStock via Getty Images Introduction In my view, Goosehead's strong growth confirms the business quality, though the current price requires almost flawless execution in the coming quarters. Goosehead Insurance, Inc. (GSHD) is an independent personal lines insurance brokerage 162 Followers Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||
|
Saved
2026-07-24 15:09
2d ago
Published
2026-07-24 10:16
2d ago
|
Unveiling SoFi Technologies (SOFI) Q2 Outlook: Wall Street Estimates for Key Metrics | FMP Stock News | |
|
Original source text
Analysts on Wall Street project that SoFi Technologies, Inc. (SOFI - Free Report) will announce quarterly earnings of $0.11 per share in its forthcoming report, representing an increase of 37.5% year over year. Revenues are projected to reach $1.11 billion, increasing 29.7% from the same quarter last year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock. While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective. Bearing this in mind, let's now explore the average estimates of specific SoFi Technologies metrics that are commonly monitored and projected by Wall Street analysts. Analysts forecast 'Net Interest Income' to reach $714.41 million. The estimate indicates a change of +38% from the prior-year quarter. The consensus among analysts is that 'Total Noninterest Income' will reach $404.45 million. The estimate points to a change of +20% from the year-ago quarter. The combined assessment of analysts suggests that 'Total Interest Income' will likely reach $1.06 billion. The estimate suggests a change of +33.2% year over year. Analysts expect 'Other' to come in at $76.93 million. The estimate indicates a change of +60.1% from the prior-year quarter. Analysts' assessment points toward 'Technology products and solutions' reaching $53.92 million. The estimate points to a change of -40.6% from the year-ago quarter. Analysts predict that the 'Loan origination, sales, and securitizations' will reach $111.75 million. The estimate indicates a change of +57.7% from the prior-year quarter. The average prediction of analysts places 'Total Accounts - Technology Platform segment' at 137.06 million. The estimate compares to the year-ago value of 160.05 million. Based on the collective assessment of analysts, 'Total Products - Financial Services segment' should arrive at 20.80 million. The estimate compares to the year-ago value of 14.86 million. View all Key Company Metrics for SoFi Technologies here>>> Shares of SoFi Technologies have demonstrated returns of -3.8% over the past month compared to the Zacks S&P 500 composite's +0.6% change. With a Zacks Rank #3 (Hold), SOFI is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> . |
|||
|
Saved
2026-07-24 15:09
2d ago
Published
2026-07-24 11:01
2d ago
|
Analysts Estimate Portland General Electric (POR) to Report a Decline in Earnings: What to Look Out for | FMP Stock News | |
|
Original source text
Portland General Electric (POR - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise. Zacks Consensus EstimateThis electric utility is expected to post quarterly earnings of $0.64 per share in its upcoming report, which represents a year-over-year change of -3%. Revenues are expected to be $846.61 million, up 4.9% from the year-ago quarter. Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 9.58% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction). The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). How Have the Numbers Shaped Up for Portland General Electric?For Portland General Electric, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%. On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination makes it difficult to conclusively predict that Portland General Electric will beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Portland General Electric would post earnings of $0.83 per share when it actually produced earnings of $0.58, delivering a surprise of -30.12%. Over the last four quarters, the company has beaten consensus EPS estimates two times. Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Portland General Electric doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. An Industry Player's Expected ResultsXcel Energy (XEL - Free Report) , another stock in the Zacks Utility - Electric Power industry, is expected to report earnings per share of $0.79 for the quarter ended June 2026. This estimate points to a year-over-year change of +5.3%. Revenues for the quarter are expected to be $3.58 billion, up 9% from the year-ago quarter. Over the last 30 days, the consensus EPS estimate for Xcel has been revised 0.5% down to the current level. Nevertheless, the company now has an Earnings ESP of -0.42%, reflecting a lower Most Accurate Estimate. When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that Xcel will beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. |
|||
|
Saved
2026-07-24 15:08
2d ago
Published
2026-07-24 09:00
2d ago
|
Starfighters Space Selects CBIZ CPAs P.C. as Independent Registered Public Accounting Firm | FMP Stock News | |
|
Original source text
KENNEDY SPACE CENTER, Fla.--(BUSINESS WIRE)--Starfighters Space, Inc. (“Starfighters Space” or the “Company”) (NYSE American: FJET), the space company operating the world's only commercial fleet of flight-ready Mach 2+ F-104 supersonic aircraft, today announced that, following a thorough evaluation process, its Audit Committee, with the approval of the Board of Directors has engaged CBIZ CPAs P.C. (“CBIZ CPAs”) to serve as the Company's independent registered public accounting firm. “Starfighte. |
|||
|
Saved
2026-07-24 15:08
2d ago
Published
2026-07-24 09:46
2d ago
|
Do Options Traders Know Something About AAON Stock We Don't? | FMP Stock News | |
|
Original source text
Investors in AAON, Inc. (AAON - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 16, 2026 $55 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy. What do the Analysts Think?Clearly, options traders are pricing in a big move for AAON shares, but what is the fundamental picture for the company? Currently, AAON is a Zacks Rank #3 (Hold) in the Building Products - Air Conditioner and Heating industry that ranks in the Top 19% of our Zacks Industry Rank. Over the last 30 days, one analyst has increased the earnings estimate for the current quarter, while none have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from $5.50 per share to $5.53 in that period. Given the way analysts feel about AAON right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected. |
|||
|
Saved
2026-07-24 15:06
2d ago
Published
2026-07-24 09:45
2d ago
|
Legend Biotech: Why I'm Ready To Go Long Again | FMP Stock News | |
|
Original source text
HomeStock IdeasLong IdeasHealthcare SummaryOn July 15, J&J, a Legend Biotech Corporation partner, announced continued strong demand for Carvykti.Sales of this CAR-T cell therapy were $657 million in the second quarter, up 10.1% quarter-on-quarter and 49.7% year-on-year.Legend hasn't yet announced when it will publish its second-quarter report, but given Carvykti's sales, I expect it to beat consensus estimates.Moreover, LB2501, a CD19/CD20 CAR T-cell therapy, has shown promising results in the Phase 1 trial in the treatment of relapsed or refractory B-cell non-Hodgkin lymphoma.In this article, I explain why I continue to cover Legend Biotech with a Strong Buy rating. Tom Merton/OJO Images via Getty Images Following my article "Legend Biotech: Undervalued Leader In The CAR-T Race," Legend Biotech Corporation (LEGN) shares rose as much as 55.8% to $37.2. But over the past 5 weeks, they've returned to the -1σ band 3.49K Followers Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||
|
Saved
2026-07-24 15:05
2d ago
Published
2026-07-24 11:01
2d ago
|
Newell Brands (NWL) Expected to Beat Earnings Estimates: Should You Buy? | FMP Stock News | |
|
Original source text
Newell Brands (NWL - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 31. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. Zacks Consensus EstimateThis consumer products company is expected to post quarterly earnings of $0.19 per share in its upcoming report, which represents a year-over-year change of -20.8%. Revenues are expected to be $1.97 billion, up 1.7% from the year-ago quarter. Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.02% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS Surprise Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only. A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). How Have the Numbers Shaped Up for Newell Brands?For Newell Brands, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +5.36%. On the other hand, the stock currently carries a Zacks Rank of #2. So, this combination indicates that Newell Brands will most likely beat the consensus EPS estimate. Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number. For the last reported quarter, it was expected that Newell Brands would post a loss of$0.09 per share when it actually produced a loss of -$0.05, delivering a surprise of +44.44%. Over the last four quarters, the company has beaten consensus EPS estimates just once. Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Newell Brands appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release. Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar. |
|||
|
Saved
2026-07-24 15:03
2d ago
Published
2026-07-24 06:16
2d ago
|
California Public Employees Retirement System Increases Stake in Knight-Swift Transportation Holdings Inc. $KNX | FMP Stock News | |
|
Original source text
Posted by Defense World Staff on Jul 24th, 2026California Public Employees Retirement System increased its position in Knight-Swift Transportation Holdings Inc. (NYSE:KNX – Free Report) by 3.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 291,883 shares of the transportation company’s stock after buying an additional 8,653 shares during the quarter. California Public Employees Retirement System owned about 0.18% of Knight-Swift Transportation worth $16,807,000 as of its most recent filing with the Securities and Exchange Commission. A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Wellington Management Group LLP boosted its stake in shares of Knight-Swift Transportation by 23.6% during the 4th quarter. Wellington Management Group LLP now owns 12,918,523 shares of the transportation company’s stock valued at $675,380,000 after buying an additional 2,468,293 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Knight-Swift Transportation by 1.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 8,397,338 shares of the transportation company’s stock valued at $439,016,000 after acquiring an additional 129,651 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Knight-Swift Transportation by 7.2% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 4,676,422 shares of the transportation company’s stock worth $244,250,000 after purchasing an additional 315,192 shares during the last quarter. Ensign Peak Advisors Inc lifted its stake in Knight-Swift Transportation by 50.4% in the fourth quarter. Ensign Peak Advisors Inc now owns 2,939,212 shares of the transportation company’s stock valued at $153,662,000 after buying an additional 984,422 shares during the last quarter. Finally, UBS Group AG lifted its position in Knight-Swift Transportation by 44.3% in the 4th quarter. UBS Group AG now owns 2,430,896 shares of the transportation company’s stock valued at $127,087,000 after purchasing an additional 745,787 shares during the last quarter. 88.77% of the stock is owned by institutional investors and hedge funds. Wall Street Analyst Weigh In A number of analysts have recently weighed in on the stock. UBS Group upped their price target on shares of Knight-Swift Transportation from $79.00 to $94.00 and gave the stock a “buy” rating in a research note on Monday, June 1st. Robert W. Baird increased their price target on Knight-Swift Transportation from $62.00 to $70.00 and gave the company an “outperform” rating in a research report on Thursday, April 23rd. Stephens raised shares of Knight-Swift Transportation to a “strong-buy” rating in a research note on Wednesday, July 8th. Susquehanna raised their price objective on Knight-Swift Transportation from $90.00 to $96.00 and gave the stock a “positive” rating in a research report on Thursday. Finally, Wells Fargo & Company boosted their price target on shares of Knight-Swift Transportation from $65.00 to $86.00 and gave the company an “overweight” rating in a report on Friday, June 5th. Three investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $84.44. Get Our Latest Stock Report on Knight-Swift Transportation Key Knight-Swift Transportation News Here are the key news stories impacting Knight-Swift Transportation this week: Positive Sentiment: Knight-Swift beat second-quarter expectations, reporting EPS of $0.63 versus consensus around $0.49-$0.51 and revenue of $2.10 billion versus estimates near $2.05 billion, with revenue up 12.6% year over year. Earnings report and transcript Positive Sentiment: The company also issued third-quarter EPS guidance of $0.71 to $0.77, above the Street’s estimate of about $0.67, which suggests management sees continued momentum. Quarterly results announcement Positive Sentiment: Several Wall Street firms lifted price targets after the results, including Bank of America to $98, Stifel to $88, Susquehanna to $96, TD Cowen to $86, and JPMorgan to $84, reflecting improved sentiment around the stock. Analyst target updates Neutral Sentiment: JPMorgan kept a neutral rating despite raising its target, while the other firms maintained more constructive views such as buy or positive. JPMorgan update Knight-Swift Transportation Stock Performance Shares of KNX opened at $72.05 on Friday. The company has a market capitalization of $11.71 billion, a PE ratio of 277.13, a price-to-earnings-growth ratio of 0.85 and a beta of 1.18. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.70 and a quick ratio of 0.70. Knight-Swift Transportation Holdings Inc. has a one year low of $38.63 and a one year high of $82.86. The company’s fifty day moving average price is $75.53 and its 200 day moving average price is $64.92. Knight-Swift Transportation (NYSE:KNX – Get Free Report) last released its earnings results on Wednesday, July 22nd. The transportation company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.12. The firm had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.05 billion. Knight-Swift Transportation had a return on equity of 3.50% and a net margin of 0.56%.The company’s revenue was up 12.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 EPS. Knight-Swift Transportation has set its Q3 2026 guidance at 0.710-0.770 EPS. As a group, analysts expect that Knight-Swift Transportation Holdings Inc. will post 2.21 earnings per share for the current year. Knight-Swift Transportation Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 22nd. Stockholders of record on Monday, June 8th were paid a $0.20 dividend. The ex-dividend date was Monday, June 8th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.1%. Knight-Swift Transportation’s dividend payout ratio is currently 380.95%. About Knight-Swift Transportation (Free Report) Knight-Swift Transportation Holdings Inc (NYSE: KNX) is one of North America’s largest asset-based truckload carriers, offering a wide range of transportation and logistics services. The company was formed in 2017 through the merger of Knight Transportation and Swift Transportation, each with decades of experience in long-haul dry van and refrigerated freight. Since the merger, Knight-Swift has pursued a growth strategy that includes fleet expansions, targeted acquisitions, and investments in technology to enhance service reliability and network efficiency. The company’s core business activities include full truckload operations for dry van, temperature-controlled and flatbed shipments. Recommended Stories Five stocks we like better than Knight-Swift Transportation Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market Receive News & Ratings for Knight-Swift Transportation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight-Swift Transportation and related companies with MarketBeat.com's FREE daily email newsletter. « PREVIOUS HEADLINEAlphabet (NASDAQ:GOOG) Price Target Raised to $475.00 at Pivotal Research NEXT HEADLINE »Dimensional Fund Advisors LP Boosts Stake in JPMorgan Chase & Co. $JPM |
|||
|
Saved
2026-07-24 15:03
2d ago
Published
2026-07-24 10:00
2d ago
|
Kaplan Fox & Kilsheimer LLP Alerts Investors of GoDaddy Inc. (NYSE: GDDY) to an Ongoing Investigation of Possible Securities Law Violations | FMP Stock News | |
|
Original source text
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a GoDaddy investor and have suffered losses, or if you have information that could assist in the GoDaddy investigation, you may CLICK HERE to contact us. |
|||
|
Saved
2026-07-24 15:03
2d ago
Published
2026-07-24 10:16
2d ago
|
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? | FMP Stock News | |
|
Original source text
A strong stock as of late has been Quest Diagnostics (DGX - Free Report) . Shares have been marching higher, with the stock up 10.5% over the past month. The stock hit a new 52-week high of $237.78 in the previous session. Quest Diagnostics has gained 31.3% since the start of the year compared to the -0.1% gain for the Zacks Medical sector and the 20.4% return for the Zacks Medical - Outpatient and Home Healthcare industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on July 23, 2026, Quest Diagnostics reported EPS of $3.12 versus consensus estimate of $2.81 while it beat the consensus revenue estimate by 2.15%. For the current fiscal year, Quest Diagnostics is expected to post earnings of $10.72 per share on $11.83 in revenues. This represents a 8.83% change in EPS on a 7.25% change in revenues. For the next fiscal year, the company is expected to earn $11.56 per share on $12.39 in revenues. This represents a year-over-year change of 7.84% and 4.69%, respectively. Valuation MetricsThough Quest Diagnostics has recently hit a 52-week high, what is next for Quest Diagnostics? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself. On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style. Quest Diagnostics has a Value Score of B. The stock's Growth and Momentum Scores are B and B, respectively, giving the company a VGM Score of B. In terms of its value breakdown, the stock currently trades at 21.3X current fiscal year EPS estimates, which is a premium to the peer industry average of 20.9X. On a trailing cash flow basis, the stock currently trades at 15X versus its peer group's average of 14.8X. Additionally, the stock has a PEG ratio of 2.72. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective. Zacks RankWe also need to consider the stock's Zacks Rank, as this is even more important than the company's VGM Score. Fortunately, Quest Diagnostics currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts. Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Quest Diagnostics fits the bill. Thus, it seems as though Quest Diagnostics shares could have a bit more room to run in the near term. How Does DGX Stack Up to the Competition?Shares of DGX have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is Aveanna Healthcare Holdings Inc. (AVAH - Free Report) . AVAH has a Zacks Rank of #2 (Buy) and a Value Score of A, a Growth Score of A, and a Momentum Score of B. Earnings were strong last quarter. Aveanna Healthcare Holdings Inc. beat our consensus estimate by 38.46%, and for the current fiscal year, AVAH is expected to post earnings of $0.73 per share on revenue of $2.65 billion. Shares of Aveanna Healthcare Holdings Inc. have gained 7.1% over the past month, and currently trade at a forward P/E of 12.44X and a P/CF of 13.17X. The Medical - Outpatient and Home Healthcare industry is in the top 39% of all the industries we have in our universe, so it looks like there are some nice tailwinds for DGX and AVAH, even beyond their own solid fundamental situation. |
|||
|
Saved
2026-07-24 15:03
2d ago
Published
2026-07-24 10:50
2d ago
|
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term | FMP Stock News | |
|
Original source text
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days. Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform. The Style Scores are broken down into four categories: Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks. Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time. Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks. VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum. How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier. Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day. With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey. That's where the Style Scores come in. You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible. The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank. For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well. Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Stock to Watch: Quest Diagnostics (DGX - Free Report) Headquartered in Secaucus, New Jersey, Quest Diagnostics Inc. provides diagnostic information services to a broad range of customers within its primary customer channels of physicians, hospitals, patients, and consumers. The company provides services to Independent Delivery Networks (IDN) throughout the United States, through its Professional Lab Services (PLS) offerings, which allow them to build and execute their laboratory strategy, improve quality, reduce healthcare costs, and focus on core competencies. The company is a key provider of reference testing for approximately half of the hospitals in the United States. DGX is a #2 (Buy) on the Zacks Rank, with a VGM Score of B. Momentum investors should take note of this Medical stock. DGX has a Momentum Style Score of B, and shares are up 10.5% over the past four weeks. One analyst revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.02 to $10.72 per share. DGX also boasts an average earnings surprise of +5.8%. With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, DGX should be on investors' short list. |
|||
|
Saved
2026-07-24 15:02
2d ago
Published
2026-07-24 09:00
2d ago
|
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction | FMP Stock News | |
|
Original source text
Represents significant milestone in the Company’s ongoing portfolio optimization efforts July 24, 2026 09:00 ET | Source: Surgery Partners, Inc.BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it, along with its existing partner Intermountain Health, has placed into escrow signature pages to definitive agreements, pursuant to which Surgery Partners would sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health. Physician ownership of Mountain View Hospital will remain unchanged. The transaction values the combined Idaho Falls facilities at approximately $1.15 billion. Total consideration to Surgery Partners is approximately $795 million. The Company expects to receive substantial cash proceeds upon closing, with the final amount subject to customary purchase price adjustments, including adjustments for indebtedness, working capital, transaction expenses and other closing items. Accordingly, the Company is unable to provide a reasonable estimate of final net cash proceeds at this time. Completion of the transaction is subject to customary closing conditions, including the execution of binding Securities Purchase Agreements between the Company and Intermountain Health following requisite Mountain View Hospital physician member and physician governing board approvals. Unless and until these approvals are obtained, there is no assurance regarding the completion of the transaction. In addition, the closing of the transaction is subject to customary closing conditions, including expiration of applicable waiting periods under the Hart-Scott-Rodino Act, obtaining any other applicable material regulatory approvals, and obtaining certain material third-party consents. The transaction is expected to close in the coming months, subject to the forgoing approvals. “For Surgery Partners, assuming physician partner approval, this transaction represents the largest step forward in our portfolio optimization strategy to date, simplifying our go forward operations, and positioning us to accelerate momentum in the rapidly growing, high-value ambulatory surgery center space,” said Eric Evans, Chief Executive Officer of Surgery Partners. “While our Idaho Falls partnerships have been a large and successful part of our Company’s growth story, these unique facilities are best positioned for their next chapter of growth with an outstanding regional health system like Intermountain. Once complete, this will further sharpen our strategic focus and help support long-term shareholder value. We are confident that Intermountain Health is the best natural owner to continue to advance the mission that Mountain View physician partners started well over two decades ago and to build on their strong legacy of exceptional patient care.” 2026 Outlook The Company’s previously issued guidance does not reflect the anticipated impact of this transaction. Excluding the impact of this transaction, the Company reaffirms its outlook for 2026 revenues to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million. The Company intends to provide further details regarding the expected financial impact of the transaction on its 2026 financial outlook at the appropriate time, subject to the completion of the transaction. Second Quarter 2026 Earnings Release Date and Conference Call Details Surgery Partners will release its second quarter 2026 results before the market opens on Monday, August 10, 2026, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until August 24, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13761354 Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call. To learn more about Surgery Partners please visit the company’s website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution of material company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company’s website and is readily accessible. About Surgery Partners Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com. About the Idaho Falls Facilities The Idaho Falls facilities have built a long-standing reputation as preferred providers and leaders in delivering high-quality, affordable care for the Idaho Falls region. Mountain View Hospital was founded in 2002 and has grown into a leading surgical hub and Level III NICU, with the opening of the Idaho Falls Community Hospital in 2019 adding scalable acute care capabilities. Combined, the locations employ over 150 physicians and include 126 beds with a breadth of services across nine surgical specialties and a diverse range of additional service lines, including oncology, emergency department and ICU services, and neonatology. About Intermountain Health Headquartered in Utah with locations in six states and additional operations across the western U.S., Intermountain Health is a nonprofit system of 34 hospitals, approximately 400 clinics, medical groups with some 4,600 employed physicians and advanced care providers, a nonprofit health plan called Select Health with more than one million members, and other health services. Helping people live the healthiest lives possible, Intermountain is committed to improving community health and is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes at sustainable costs. Cautionary Statement Regarding Forward Looking Statements This press release contains forward-looking statements, including those regarding growth, our anticipated operating results for future periods and other similar statements. These statements can be identified by the use of words such as "believes," "anticipates," "expects," "intends," "plans," "continues," "estimates," "predicts," "projects," "forecasts," "may," "could," and similar expressions. All forward-looking statements are based on current expectations and beliefs as of the date of this release and are subject to risks, uncertainties and other factors that may cause actual results to differ materially from the expectations discussed in, or implied by, the forward-looking statements. Many of these factors are beyond our ability to control or predict including, without limitation, the risk that the potential sale transaction may not be completed in a timely manner or at all, including the risk that required physician, regulatory and other approvals and consents are not obtained, are delayed, or are obtained subject to conditions that are not anticipated; the failure to satisfy other closing conditions to the transaction; the possibility that the anticipated benefits of the sale to the Company are not realized as expected, the potential adverse effect of the announcement or pendency of the transaction on the market price of, or trading in, the Company’s securities and on the Company's business relationships, operating results, and business generally, including the ability to retain key personnel; risks related to diverting management's attention from the Company's ongoing business operations; the amount of costs, fees, expenses, and charges related to the sale transaction; potential litigation relating to the transaction that could be instituted against the Company or its affiliates, officers, or directors, and the effects of any outcomes related thereto; reductions in payments from government health care programs and private insurance payors, such as health maintenance organizations, preferred provider organizations, and other managed care organizations and employers; our ability to contract with private insurance payors; changes in our payor mix or surgical case mix; failure to maintain or develop relationships with physicians on beneficial or favorable terms, or at all; the impact of payor controls designed to reduce the number of surgical procedures; our efforts to integrate operations of acquired or developed businesses and surgical facilities, attract new physician partners, or acquire additional surgical facilities; supply chain issues, including shortages or quality control issues with surgery-related products, equipment and medical supplies; competition for physicians, nurses, strategic relationships, acquisitions and managed care contracts; our ability to attract and retain qualified health care professionals; our ability to enforce non-compete restrictions against our physicians; our ability to manage material liabilities whether known or unknown incurred as a result of acquiring or operating surgical facilities; the impact of future legislation and other health care regulatory reform actions, and the effect of that legislation and other regulatory actions on our business; our ability to comply with current health care laws and regulations; the outcome of legal and regulatory proceedings that have been or may be brought against us; the impact of cybersecurity attacks or intrusions, changes in the regulatory, economic and other conditions of the states where our surgical facilities are located; our indebtedness; the social and economic impact of a pandemic, epidemic or outbreak of a contagious disease on our business; and the risks and uncertainties identified and discussed from time to time in the Company’s reports filed with the Securities and Exchange Commission (the "SEC"), including in Item 1A under the heading "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and other reports filed with the SEC. Except as required by law, the Company undertakes no obligation to revise or update publicly any forward-looking statements to reflect events or circumstances after the date of this report, or to reflect the occurrence of unanticipated events or circumstances. Contacts Media/Investor Contact Surgery Partners Investor Relations (615) 234-8940 [email protected] Intermountain Health Media Relations [email protected] |
|||
|
Saved
2026-07-24 15:01
2d ago
Published
2026-07-24 10:46
2d ago
|
Why Burlington Stores (BURL) is a Top Growth Stock for the Long-Term | FMP Stock News | |
|
Original source text
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days. Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform. The Style Scores are broken down into four categories: Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks. Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time. Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks. VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank. How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier. #1 (Strong Buy) stocks have produced an unmatched +23.94% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day. This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio. That's where the Style Scores come in. To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible. The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank. A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too. Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Stock to Watch: Burlington Stores (BURL - Free Report) Founded in 1972 and headquartered in New Jersey, Burlington Stores, Inc. is a Fortune 500 company and an off-price retailer operating in the United States and Puerto Rico. Through its subsidiary, Burlington Coat Factory Warehouse Corporation, the company provides a line of value-priced products, including women’s ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. BURL is a #2 (Buy) on the Zacks Rank, with a VGM Score of B. Additionally, the company could be a top pick for growth investors. BURL has a Growth Style Score of A, forecasting year-over-year earnings growth of 20% for the current fiscal year. For fiscal 2027, five analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.36 to $11.71 per share. BURL boasts an average earnings surprise of +14%. With a solid Zacks Rank and top-tier Growth and VGM Style Scores, BURL should be on investors' short list. |
|||
|
Saved
2026-07-24 15:00
2d ago
Published
2026-07-24 10:31
2d ago
|
Is It Worth Investing in SkyWest (SKYW) Based on Wall Street's Bullish Views? | FMP Stock News | |
|
Original source text
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about SkyWest (SKYW - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage. SkyWest currently has an average brokerage recommendation (ABR) of 1.86, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by seven brokerage firms. An ABR of 1.86 approximates between Strong Buy and Buy. Of the seven recommendations that derive the current ABR, four are Strong Buy, representing 57.1% of all recommendations. Brokerage Recommendation Trends for SKYW Check price target & stock forecast for SkyWest here>>> The ABR suggests buying SkyWest, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation. Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations. This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements. Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision. Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether. Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5. Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide. In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research. Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns. Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements. Should You Invest in SKYW?Looking at the earnings estimate revisions for SkyWest, the Zacks Consensus Estimate for the current year has declined 1% over the past month to $10.88. Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for SkyWest. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Therefore, it could be wise to take the Buy-equivalent ABR for SkyWest with a grain of salt. |
|||
|
Saved
2026-07-24 15:00
2d ago
Published
2026-07-24 10:16
2d ago
|
Curious about Sprouts Farmers (SFM) Q2 Performance? Explore Wall Street Estimates for Key Metrics | FMP Stock News | |
|
Original source text
Wall Street analysts expect Sprouts Farmers (SFM - Free Report) to post quarterly earnings of $1.35 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $2.33 billion, up 4.9% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.8% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock. While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. In light of this perspective, let's dive into the average estimates of certain Sprouts Farmers metrics that are commonly tracked and forecasted by Wall Street analysts. According to the collective judgment of analysts, 'Comparable store sales growth' should come in at -0.8%. Compared to the current estimate, the company reported 10.2% in the same quarter of the previous year. Analysts expect 'Stores at end of period' to come in at 492 . The estimate is in contrast to the year-ago figure of 455 . The average prediction of analysts places 'New Stores Opened' at 8 . The estimate is in contrast to the year-ago figure of 12 . The combined assessment of analysts suggests that 'Stores at beginning of period' will likely reach 483 . The estimate is in contrast to the year-ago figure of 443 . View all Key Company Metrics for Sprouts Farmers here>>> Shares of Sprouts Farmers have experienced a change of -10.4% in the past month compared to the +0.6% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), SFM is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> . |
|||
|
Saved
2026-07-24 15:00
2d ago
Published
2026-07-24 10:10
2d ago
|
HELE Investors are Reminded of the Pending Lead Plaintiff Deadline on August 3, 2026; Contact Robbins LLP for Information About Recovering Your Losses | FMP Stock News | |
|
Original source text
SAN DIEGO, July 24, 2026 (GLOBE NEWSWIRE) --Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Helen of Troy Limited (NASDAQ: HELE) common stock between April 24, 2024 and October 8, 2025. Helen of Troy markets a variety of consumer goods across several segments. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? April 24, 2024 - October 8, 2025 What are the allegations? Shareholders allege that Helen of Troy Limited misled investors regarding the ability of Project Pegasus to improve efficiency and effectiveness. According to the complaint, in fiscal year 2023, Helen of Troy initiated Project Pegasus, a “global restructuring program that focused on both efficiency and effectiveness.” As a part of this initiative, the Company invested in a new distribution center in Tennessee to support its targeted growth. Plaintiff alleges that during the class period, the Company boasted about the “fuel” it was generating from Project Pegasus. Although Helen of Troy admitted to some speed bumps in Project Pegasus, specifically citing “implementation hiccups” with its new Tennessee distribution center, defendants assured investors that “despite the delayed savings related to our Tennessee distribution center, Project Pegasus continues to move forward. We have made good progress on the cost of goods sold work streams, implementing multiple projects that reduce costs and simplify our supplier base.” However, Project Pegasus was not delivering the efficiencies that defendants touted. Rather, unknown to investors, Helen of Troy did not have enough resources or the budget to achieve its stated restructuring or savings goals. Plaintiff alleges that on October 9, 2025, CEO G. Scott Uzzell reported Helen of Troy’s second quarter results for fiscal year 2026, announcing that quarterly sales were down 8.9% year-over-year, adjusted earnings per share plummeted by 51%, and that these results were caused by significant business disruptions and cost headwinds which the Company expects to persist for the remainder of the year. These disclosures caused Helen of Troy’s stock price to decline by $6.90 per share, or 25%. What can shareholders do now? You may be eligible to participate in the class action against Helen of Troy Limited. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by August 3, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Helen of Troy Limited settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. |
|||
|
Saved
2026-07-24 14:59
2d ago
Published
2026-07-24 10:12
2d ago
|
Canadian Solar opens US solar cell factory in Indiana | FMP Stock News | |
|
Original source text
Miniatures of solar panel and electric pole are seen in front of Canadian Solar logo in this illustration taken January 17, 2023. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tabCompaniesJuly 24 (Reuters) - Canadian Solar (CSIQ.O), opens new tab opened a solar cell factory in Indiana on Friday that the company says will help fill a major gap in U.S. solar manufacturing by producing a key component that is largely produced in Asia. The U.S. is seeking to build a domestic solar supply chain through tax incentives and trade measures aimed at reducing dependence on imports. China controls about 80% of the global solar supply chain. The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here. The nearly $1 billion investment by Canadian Solar's U.S. manufacturing arm, CS PowerTech, is expected to produce 6 gigawatts of cells annually and employ more than 1,200 people once it reaches full production by early next year. "For us this is a tremendous milestone," Canadian Solar CEO Colin Parkin said in an interview. Canadian Solar, which is based in Ontario, Canada, is one of the biggest solar equipment manufacturers in the world, with factories in China, Southeast Asia and the United States. The Jeffersonville, Indiana, facility is the first U.S. plant designed to make heterojunction, or HJT, solar cells, a high-efficiency technology that Parkin said offers better performance than conventional technologies and has more room for future improvements. The United States has added significant solar module assembly capacity since the 2022 Inflation Reduction Act created a tax credit for advanced clean energy manufacturing. But production of cells that are assembled into panels has lagged, leaving manufacturers dependent on imports. Output from the Jeffersonville plant will be used by Canadian Solar's module factory in Mesquite, Texas, which is being expanded to 10 GW of annual capacity. "It will directly reduce our reliance on imported cells," Parkin said, though the company will still depend on some imports. U.S. tariffs on solar imports and manufacturing incentives helped justify the investment, Parkin said, adding that producing both cells and modules domestically allows the company to capture the full value of available tax incentives. Canadian Solar is also actively evaluating investments further upstream in the solar supply chain, he said. Reporting by Nichola Groom; Editing by Nia Williams Our Standards: The Thomson Reuters Trust Principles., opens new tab |
|||
|
Saved
2026-07-24 14:58
2d ago
Published
2026-07-24 09:56
2d ago
|
Why Fast-paced Mover Cleveland-Cliffs (CLF) Is a Great Choice for Value Investors | FMP Stock News | |
|
Original source text
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks and waiting long for them to recover. They believe instead that one could make far more money in lesser time by "buying high and selling higher."Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, investors find themselves loaded up on expensive shares with limited to no upside or even a downside. So, going all-in on momentum could be risky at times. It could be safer to invest in bargain stocks that have been witnessing price momentum recently. While the Zacks Momentum Style Score (part of the Zacks Style Scores system), which pays close attention to trends in a stock's price or earnings, is pretty useful in identifying great momentum stocks, our 'Fast-Paced Momentum at a Bargain' screen comes handy in spotting fast-moving stocks that are still attractively priced. There are several stocks that currently pass through the screen and Cleveland-Cliffs (CLF - Free Report) is one of them. Here are the key reasons why this stock is a great candidate. Investors' growing interest in a stock is reflected in its recent price increase. A price change of 1.9% over the past four weeks positions the stock of this mining company well in this regard. While any stock can see a spike in price for a short period, it takes a real momentum player to deliver positive returns for a longer time frame. CLF meets this criterion too, as the stock gained 7.5% over the past 12 weeks. Moreover, the momentum for CLF is fast paced, as the stock currently has a beta of 2.13. This indicates that the stock moves 113% higher than the market in either direction. Given this price performance, it is no surprise that CLF has a Momentum Score of A, which indicates that this is the right time to enter the stock to take advantage of the momentum with the highest probability of success. In addition to a favorable Momentum Score, an upward trend in earnings estimate revisions has helped CLF earn a Zacks Rank #2 (Buy). Our research shows that the momentum-effect is quite strong among Zacks Rank #1 and #2 stocks. That's because as covering analysts raise their earnings estimates for a stock, more and more investors take an interest in it, helping its price race to keep up. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Most importantly, despite possessing fast-paced momentum features, CLF is trading at a reasonable valuation. In terms of Price-to-Sales ratio, which is considered as one of the best valuation metrics, the stock looks quite cheap now. CLF is currently trading at 0.33 times its sales. In other words, investors need to pay only 33 cents for each dollar of sales. So, CLF appears to have plenty of room to run, and that too at a fast pace. In addition to CLF, there are several other stocks that currently pass through our 'Fast-Paced Momentum at a Bargain' screen. You may consider investing in them and start looking for the newest stocks that fit these criteria. This is not the only screen that could help you find your next winning stock pick. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market. However, keep in mind that the key to a successful stock-picking strategy is to ensure that it produced profitable results in the past. You could easily do that with the help of the Zacks Research Wizard. In addition to allowing you to backtest the effectiveness of your strategy, the program comes loaded with some of our most successful stock-picking strategies. Click here to sign up for a free trial to the Research Wizard today. |
|||
|
Saved
2026-07-24 14:58
2d ago
Published
2026-07-24 10:32
2d ago
|
Mobileye's 15% Drop: Why I'm Still Not Buying This Robotaxi Play | FMP Stock News | |
|
Original source text
7.01K FollowersAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body. |
|||
|
Saved
2026-07-24 14:58
2d ago
Published
2026-07-24 10:00
2d ago
|
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now? | FMP Stock News | |
|
Original source text
Hims & Hers Health, Inc. (HIMS - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this company have returned +0.1% over the past month versus the Zacks S&P 500 composite's +0.6% change. The Zacks Medical Info Systems industry, to which Hims & Hers Health belongs, has gained 5.3% over this period. Now the key question is: Where could the stock be headed in the near term? Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision. Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock. Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. For the current quarter, Hims & Hers Health is expected to post a loss of $0.07 per share, indicating a change of -141.2% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.3% over the last 30 days. For the current fiscal year, the consensus earnings estimate of -$0.27 points to a change of -150.9% from the prior year. Over the last 30 days, this estimate has changed -49.2%. For the next fiscal year, the consensus earnings estimate of $0.52 indicates a change of +291.4% from what Hims & Hers Health is expected to report a year ago. Over the past month, the estimate has changed +2.5%. Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Hims & Hers Health is rated Zacks Rank #3 (Hold). The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: 12 Month EPS Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial. For Hims & Hers Health, the consensus sales estimate for the current quarter of $690.21 million indicates a year-over-year change of +26.7%. For the current and next fiscal years, $2.91 billion and $3.38 billion estimates indicate +23.8% and +16.4% changes, respectively. Last Reported Results and Surprise HistoryHims & Hers Health reported revenues of $608.1 million in the last reported quarter, representing a year-over-year change of +3.8%. EPS of -$0.18 for the same period compares with $0.2 a year ago. Compared to the Zacks Consensus Estimate of $619.62 million, the reported revenues represent a surprise of -1.86%. The EPS surprise was -550%. Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates just once over this period. ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance. While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price. The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued. Hims & Hers Health is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade. ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Hims & Hers Health. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term. |
|||
|
Saved
2026-07-24 14:57
2d ago
Published
2026-07-24 10:15
2d ago
|
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (FULC) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation | FMP Stock News | |
|
Original source text
New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. ("Fulcrum Therapeutics" or the "Company") (NASDAQ: FULC).CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Fulcrum Therapeutics investor and have suffered losses, or if you have information that could assist in the Fulcrum Therapeutics investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (212) 329-8571. Fulcrum Therapeutics is a "clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with rare hematological disorders[.]" On June 1, 2026, after market close, Fulcrum Therapeutics announced in a press release "the discontinuation of its pociredir program for the treatment of SCD [(sickle cell disease).]" The Company stated that the "meeting minutes from recent end-of-phase interactions with the [U.S. Food and Drug Administration ("FDA")]" "reflected heightened FDA concerns regarding pociredir's benefit-risk profile in SCD, stemming from an unexpectedly high rate of secondary hematologic malignancies observed with Tazverik® (tazemetostat), another PRC2 inhibitor, which was withdrawn from the global market in March 2026." After submitting further information, the FDA "concluded that any pharmacological intervention targeting the PRC2 complex carries equivalent malignancy risk regardless of the specific subunit engaged." As a result, the Company has "no viable regulatory path forward for further clinical development of pociredir." Following this news, the price of Fulcrum Therapeutics stock declined from a closing price on June 1, 2026 of $6.42 per share to close at $3.14 per share on June 2, 2026, a decline of $3.28 per share, or by 51.09%. WHY CONTACT KAPLAN FOX? Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented. Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch. For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this investigation, please contact: Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. https://www.kaplanfox.com/case/fulcrum-therapeutics-inc-investigation-learn-more-now/ To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306380 Source: Kaplan Fox & Kilsheimer LLP Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs. Contact Us |
|||
|
Saved
2026-07-24 14:56
2d ago
Published
2026-07-24 09:11
2d ago
|
Reddit: Why I'm Staying Bullish Into The Q2 Print | FMP Stock News | |
|
Original source text
Reddit remains a Buy into Q2, with supportive valuations and a statistical edge for pre-earnings positioning despite recent volatility. RDDT's Q2 guidance implies 43-45% YoY revenue growth and a 40% EBITDA margin, but consensus expects a beat, even against tough comps. The Google licensing overhang introduces significant uncertainty, yet I see limited direct revenue risk and asymmetric upside if renegotiation occurs. |
|||